<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN"  "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">105005</article-id><article-id pub-id-type="doi">10.7554/eLife.105005</article-id><article-id pub-id-type="doi" specific-use="version">10.7554/eLife.105005.3</article-id><article-version article-version-type="publication-state">version of record</article-version><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Structural Biology and Molecular Biophysics</subject></subj-group></article-categories><title-group><article-title>Functionally important residues from graph analysis of coevolved dynamic couplings</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>Xu</surname><given-names>Manming</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Dantu</surname><given-names>Sarath Chandra</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-2019-5311</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Garnett</surname><given-names>James A</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Bonomo</surname><given-names>Robert A</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Pandini</surname><given-names>Alessandro</given-names></name><email>alessandro.pandini@brunel.ac.uk</email><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" equal-contrib="yes"><name><surname>Haider</surname><given-names>Shozeb</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-2650-2925</contrib-id><email>shozeb.haider@ucl.ac.uk</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="aff" rid="aff10">10</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf2"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02jx3x895</institution-id><institution>UCL School of Pharmacy</institution></institution-wrap><addr-line><named-content content-type="city">London</named-content></addr-line><country>United Kingdom</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00dn4t376</institution-id><institution>Department of Computer Science, Brunel University London</institution></institution-wrap><addr-line><named-content content-type="city">Uxbridge</named-content></addr-line><country>United Kingdom</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0220mzb33</institution-id><institution>Centre for Host-Microbiome Interactions, Faculty of Dentistry, Oral &amp; Craniofacial Sciences, King’s College London</institution></institution-wrap><addr-line><named-content content-type="city">London</named-content></addr-line><country>United Kingdom</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01vrybr67</institution-id><institution>Research Service, Louis Stokes Cleveland Department of Veterans Affairs Medical Center</institution></institution-wrap><addr-line><named-content content-type="city">Cleveland</named-content></addr-line><country>United States</country></aff><aff id="aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/051fd9666</institution-id><institution>Department of Molecular Biology and Microbiology, Case Western Reserve University School of Medicine</institution></institution-wrap><addr-line><named-content content-type="city">Cleveland</named-content></addr-line><country>United States</country></aff><aff id="aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/051fd9666</institution-id><institution>Department of Medicine, Case Western Reserve University School of Medicine</institution></institution-wrap><addr-line><named-content content-type="city">Cleveland</named-content></addr-line><country>United States</country></aff><aff id="aff7"><label>7</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/051fd9666</institution-id><institution>Departments of Pharmacology, Biochemistry, and Proteomics and Bioinformatics Case Western Reserve University School of Medicine</institution></institution-wrap><addr-line><named-content content-type="city">Cleveland</named-content></addr-line><country>United States</country></aff><aff id="aff8"><label>8</label><institution>CWRU-Cleveland VAMC Center for Antimicrobial Resistance and Epidemiology (Case VA CARES)</institution><addr-line><named-content content-type="city">Cleveland</named-content></addr-line><country>United States</country></aff><aff id="aff9"><label>9</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04yej8x59</institution-id><institution>University of Tabuk (PFSCBR)</institution></institution-wrap><addr-line><named-content content-type="city">Tabuk</named-content></addr-line><country>Saudi Arabia</country></aff><aff id="aff10"><label>10</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02jx3x895</institution-id><institution>UCL Center for Advanced Research Computing, University College London</institution></institution-wrap><addr-line><named-content content-type="city">London</named-content></addr-line><country>United Kingdom</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Gupta</surname><given-names>Yogesh K</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02f6dcw23</institution-id><institution>The University of Texas Health Science Center at San Antonio</institution></institution-wrap><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Cui</surname><given-names>Qiang</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05qwgg493</institution-id><institution>Boston University</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><author-notes><fn fn-type="con" id="equal-contrib1"><label>†</label><p>These authors contributed equally to this work</p></fn></author-notes><pub-date publication-format="electronic" date-type="publication"><day>28</day><month>03</month><year>2025</year></pub-date><volume>14</volume><elocation-id>RP105005</elocation-id><history><date date-type="sent-for-review" iso-8601-date="2024-11-08"><day>08</day><month>11</month><year>2024</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint.</event-desc><date date-type="preprint" iso-8601-date="2024-11-03"><day>03</day><month>11</month><year>2024</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2024.10.30.621065"/></event><event><event-desc>This manuscript was published as a reviewed preprint.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2025-01-16"><day>16</day><month>01</month><year>2025</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.105005.1"/></event><event><event-desc>The reviewed preprint was revised.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2025-03-12"><day>12</day><month>03</month><year>2025</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.105005.2"/></event></pub-history><permissions><copyright-statement>© 2025, Xu, Dantu et al</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>Xu, Dantu et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-105005-v1.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-105005-figures-v1.pdf"/><abstract><p>The relationship between protein dynamics and function is essential for understanding biological processes and developing effective therapeutics. Functional sites within proteins are critical for activities such as substrate binding, catalysis, and structural changes. Existing computational methods for the predictions of functional residues are trained on sequence, structural, and experimental data, but they do not explicitly model the influence of evolution on protein dynamics. This overlooked contribution is essential as it is known that evolution can fine-tune protein dynamics through compensatory mutations either to improve the proteins’ performance or diversify its function while maintaining the same structural scaffold. To model this critical contribution, we introduce DyNoPy, a computational method that combines residue coevolution analysis with molecular dynamics simulations, revealing hidden correlations between functional sites. DyNoPy constructs a graph model of residue–residue interactions, identifies communities of key residue groups, and annotates critical sites based on their roles. By leveraging the concept of coevolved dynamical couplings—residue pairs with critical dynamical interactions that have been preserved during evolution—DyNoPy offers a powerful method for predicting and analysing protein evolution and dynamics. We demonstrate the effectiveness of DyNoPy on SHV-1 and PDC-3, chromosomally encoded β-lactamases linked to antibiotic resistance, highlighting its potential to inform drug design and address pressing healthcare challenges.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>molecular dynamics</kwd><kwd>DyNoPy</kwd><kwd>coevolution</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Other</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000275</institution-id><institution>Leverhulme Trust</institution></institution-wrap></funding-source><award-id>RPG-2017-222</award-id><principal-award-recipient><name><surname>Garnett</surname><given-names>James A</given-names></name><name><surname>Pandini</surname><given-names>Alessandro</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>DyNoPy is able to deconvolute communities from complicated coevolution analysis.</meta-value></custom-meta><custom-meta specific-use="meta-only"><meta-name>publishing-route</meta-name><meta-value>prc</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Quantifying the contribution of individual residues or residue groups to protein function is important to estimate the pathogenic effect of mutations (<xref ref-type="bibr" rid="bib86">Stenson et al., 2017</xref>). Identifying the functional roles of individual residues has primarily been done through mutagenesis experiments (<xref ref-type="bibr" rid="bib54">Matreyek et al., 2018</xref>). Bioinformatics methods have complemented these approaches through analysis of multiple sequence alignments (MSA) of homologous proteins and structural data (<xref ref-type="bibr" rid="bib72">Poelwijk et al., 2016</xref>; <xref ref-type="bibr" rid="bib38">Høie et al., 2022</xref>; <xref ref-type="bibr" rid="bib11">Blaabjerg et al., 2023</xref>; <xref ref-type="bibr" rid="bib29">Dunham and Beltrao, 2021</xref>; <xref ref-type="bibr" rid="bib39">Hopf et al., 2017</xref>; <xref ref-type="bibr" rid="bib78">Radivojac et al., 2013</xref>). Among these methods, computational techniques that can decode inter-residue evolutionary relationships from MSAs have paved the way for machine learning (ML)-based strategies that can predict protein structure (<xref ref-type="bibr" rid="bib43">Jumper et al., 2021</xref>; <xref ref-type="bibr" rid="bib47">Lin et al., 2023</xref>; <xref ref-type="bibr" rid="bib4">Baek et al., 2021</xref>; <xref ref-type="bibr" rid="bib51">Marks et al., 2012</xref>), stability (<xref ref-type="bibr" rid="bib14">Broom et al., 2020</xref>), and function (<xref ref-type="bibr" rid="bib39">Hopf et al., 2017</xref>) and extend the scope of computational protein design (<xref ref-type="bibr" rid="bib27">Ding et al., 2024</xref>; <xref ref-type="bibr" rid="bib90">Wu et al., 2019</xref>; <xref ref-type="bibr" rid="bib81">Russ et al., 2020</xref>). A most recent approach has combined experimental data from three proteins, NUDT15, PTEN, and CYP2C9, on the stability and function with sequence and structural features to train an ML model to predict functional sites (<xref ref-type="bibr" rid="bib17">Cagiada et al., 2023</xref>).</p><p>Functional sites are often regulated by both local and global interactions. Changes in these interactions are instrumental for functional events like substrate binding, catalysis, and conformational changes (<xref ref-type="bibr" rid="bib89">Wodak et al., 2019</xref>). The development of physical models of protein dynamics and the increase in available computational power has stimulated the adoption of computational techniques (<xref ref-type="bibr" rid="bib18">Campitelli et al., 2020</xref>; <xref ref-type="bibr" rid="bib80">Rodrigues et al., 2021</xref>) to investigate the conformational dynamics of proteins, an essential component of the many biological functions (<xref ref-type="bibr" rid="bib37">Henzler-Wildman and Kern, 2007</xref>; <xref ref-type="bibr" rid="bib42">James and Tawfik, 2003</xref>). Different models have been proposed to describe the interactions between residues during simulations and network models have been particularly popular, including methods on single structures and molecular dynamics (MD) simulations data built by analysing the response to external forces on residue networks (<xref ref-type="bibr" rid="bib60">Nevin Gerek et al., 2013</xref>), estimating the prevalence of non-covalent energy interaction networks in homologous proteins (<xref ref-type="bibr" rid="bib91">Yehorova et al., 2024</xref>), or analysing linear or non-linear correlation in atomic fluctuations (<xref ref-type="bibr" rid="bib45">Lange and Grubmüller, 2006</xref>; <xref ref-type="bibr" rid="bib65">Osuna, 2021</xref>). These techniques have demonstrated their usefulness in extracting allosteric networks from structural data with applications in enzyme design (<xref ref-type="bibr" rid="bib65">Osuna, 2021</xref>).</p><p>However, none of these techniques incorporate information on residue evolution into the computational approach, while it has been established that evolution through compensatory mutations in dynamic regions, like hinges and loops, can fine-tune protein structural dynamics and introduce promiscuity, thereby diversifying biological function. Assuming that protein functional dynamics is conserved during evolution, significant information on dynamic regions and substrate recognition sites should be recoverable using inter-residue coevolution scores extracted from MSAs (<xref ref-type="bibr" rid="bib35">Granata et al., 2017</xref>; <xref ref-type="bibr" rid="bib48">Liu and Bahar, 2012</xref>). Coevolution analysis and MD simulations have independently (<xref ref-type="bibr" rid="bib69">Parente et al., 2015</xref>) and synergistically been combined in the past to identify important residues for function (<xref ref-type="bibr" rid="bib75">Ponzoni et al., 2015</xref>; <xref ref-type="bibr" rid="bib87">Sutto et al., 2015</xref>; <xref ref-type="bibr" rid="bib30">Estabrook et al., 2005</xref>; <xref ref-type="bibr" rid="bib21">Chen et al., 2011</xref>; <xref ref-type="bibr" rid="bib88">Wang et al., 2013</xref>). Yet a method that combines hidden information on dynamics from evolution with direct information on local and global dynamics from conformational ensembles from MD is not yet available.</p><p>Here, we present DyNoPy, a computational method that can extract hidden information on functional sites from the combination of pairwise residue coevolution data and powerful descriptors of dynamics extracted from the analysis of MD ensembles. The method can detect coevolved dynamic couplings, that is, residue pairs with critical dynamical interactions that have been preserved during evolution. These pairs are extracted from a graph model of residue–residue interactions. Communities of important residue groups are detected, and critical sites are identified by their eigenvector centrality in the graph (<xref ref-type="fig" rid="fig1">Figure 1</xref>). We demonstrate the power of this approach on SHV-1 and PDC-3 β-lactamases of major clinical importance (<xref ref-type="bibr" rid="bib64">Olehnovics et al., 2021</xref>; <xref ref-type="bibr" rid="bib22">Chen et al., 2024</xref>). DyNoPy successfully detects residue couplings that align with previous studies, guide in the explanations of mutation sites with previously unexplained mechanisms, and provide predictions on plausible important sites for the emergence of clinically relevant variants.</p><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Overview of the DyNoPy workflow.</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-105005-fig1-v1.tif"/></fig></sec><sec id="s2" sec-type="results|discussion"><title>Results and discussion</title><p>β-Lactamases are a group of enzymes capable of hydrolysing β-lactams, conferring resistance to β-lactam antibiotics (<xref ref-type="bibr" rid="bib76">Poole, 2004</xref>). These enzymes are evolving rapidly as single amino acid substitutions are sufficient to drive their evolution and increase their catalytic spectrum and inhibitor resistance profile (<xref ref-type="bibr" rid="bib16">Bush, 2018</xref>). The widespread dissemination of β-lactamases across different bacterial species and their extensive emergence highlight their global impact on antibiotic resistance (<xref ref-type="bibr" rid="bib15">Bush, 2013</xref>). The rapid evolution of β-lactamases and their clinical significance (<xref ref-type="bibr" rid="bib16">Bush, 2018</xref>) makes them an ideal target for evaluating the robustness of DyNoPy.</p><p>In this study, we applied DyNoPy to two model enzymes from different β-lactamase families: class A β-lactamase SHV-1 (a chromosomally encoded enzyme in <italic>Klebsiella pneumoniae</italic>) and class C β-lactamase PDC-3 (a chromosomally encoded enzyme in <italic>Pseudomonas aeruginosa</italic>) (<xref ref-type="bibr" rid="bib64">Olehnovics et al., 2021</xref>; <xref ref-type="bibr" rid="bib22">Chen et al., 2024</xref>; <xref ref-type="fig" rid="fig2">Figure 2</xref>). Both class A and class C β-lactamases comprise an α/β domain and an α helical domain, with the active site situated in between (<xref ref-type="bibr" rid="bib53">Matagne et al., 1998</xref>; <xref ref-type="bibr" rid="bib71">Philippon et al., 2022</xref>). Moreover, both enzymes target the carbonyl carbon of the β-lactams using a highly conserved serine residue (<xref ref-type="bibr" rid="bib67">Palzkill, 2018</xref>; <xref ref-type="bibr" rid="bib41">Jacoby, 2009</xref>). Despite these similarities, the structures of class A and class C β-lactamases are remarkably different (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplements 1</xref> and <xref ref-type="fig" rid="fig2s2">2</xref>). In class A β-lactamases, the active site is surrounded by three loops: the α3-α4 loop (residues 101–111), the Ω-loop (residues 164–179), and the hinge region (residues 213–218) (<xref ref-type="bibr" rid="bib32">Galdadas et al., 2021</xref>). The Ω-loop is particularly critical as it positions N<sub>170</sub> to hydrogen bond with the E<sub>166</sub> via a conserved water molecule, which is essential for initiating the deacylation step (<xref ref-type="bibr" rid="bib44">Kuzin et al., 1999</xref>). Compared to class A β-lactamases, the active site of class C β-lactamases is wider, conferring a broader substrate binding capability (<xref ref-type="bibr" rid="bib55">Medeiros, 1997</xref>; <xref ref-type="fig" rid="fig2s3">Figure 2—figure supplement 3</xref>). The active site of class C β-lactamases can be divided into two parts: the R1 site and the R2 site (<xref ref-type="bibr" rid="bib41">Jacoby, 2009</xref>). The R1 region is surrounded by the extended Ω-loop (residues 183–226), while the R2 site is enclosed by the R2-loop (residues 280–310) (<xref ref-type="bibr" rid="bib22">Chen et al., 2024</xref>). The Ω-loop in class C β-lactamases is significantly longer than that in class A, enhancing the active site ability to accommodate diverse substrates and contributing to the extended spectrum profile of some class C enzymes (<xref ref-type="bibr" rid="bib22">Chen et al., 2024</xref>).</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Structural Comparison of SHV-1 (PDB ID: 3N4I) and PDC-3 (PDB ID: 4HEF) β-lactamases.</title><p>Catalytic serine S<sub>70</sub> (SHV-1) and S<sub>64</sub> (PDC3) are highlighted using stick representation. Important loops surrounding the active site are highlighted in red. In SHV-1, highlighted loops are the α3-α4 loop (residues 101–111), the Ω-loop (residues 164–179), and the hinge region (residues 213–218). In PDC-3, highlighted loops are the Ω-loop (residues 183–226) and the R2-loop (residues 280–310).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-105005-fig2-v1.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>SHV-1 structural nomenclature.</title><p>PDB ID: 3N4I.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-105005-fig2-figsupp1-v1.tif"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 2.</label><caption><title>PDC-3 structural nomenclature.</title><p>PDB ID: 4HEF.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-105005-fig2-figsupp2-v1.tif"/></fig><fig id="fig2s3" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 3.</label><caption><title>Crystal structure and binding pocket of SHV-1 (PDB ID: 3N4I) and PDC-3 (PDB ID: 4HEF).</title><p>S<sub>70</sub> and S<sub>64</sub> are the catalytic serine residue for SHV-1 and PDC-3, respectively. The α3-α4 loop, the Ω-loop, and the hinge region in SHV-1 are highlighted in red. The Ω-loop and the R2-loop in PDC-3 are coloured in red.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-105005-fig2-figsupp3-v1.tif"/></fig></fig-group><p>SHV-1 is a very well-characterized enzyme with a wealth of information on mutations and their corresponding effects on protein function. In contrast, the information available on PDC-3 remains limited. Essential catalytic residues in SHV-1 are S<sub>70</sub>, K<sub>73</sub>, S<sub>130</sub>, E<sub>166</sub>, N<sub>170</sub>, K<sub>234</sub>, G<sub>236</sub>, and A<sub>237</sub> (<xref ref-type="bibr" rid="bib3">Ambler et al., 1991</xref>), and conserved catalytic residues in PDC-3 include S<sub>64</sub>, K<sub>67</sub>, Y<sub>150</sub>, N<sub>152</sub>, K<sub>315</sub>, T<sub>316</sub>, and G<sub>317</sub>. Highly conserved stretches of 3–9 hydrophobic residues, annotated as hydrophobic nodes, exist in class A β-lactamases and have been proven to be essential for protein stability (<xref ref-type="bibr" rid="bib31">Galdadas et al., 2018</xref>). Residues defined as belonging to hydrophobic nodes within SHV-1 are listed in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1a</xref>.</p><p>In SHV-1, the predominant extended spectrum β-lactamase (ESBL) substitutions occur at L<sub>35</sub>, G<sub>238</sub>, and E<sub>240</sub>, while R<sub>43</sub>, E<sub>64</sub>, D<sub>104</sub>, A<sub>146</sub>, G<sub>156</sub>, D<sub>179</sub>, R<sub>202</sub>, and R<sub>205</sub> appear in ESBLs with lower frequency (<xref ref-type="bibr" rid="bib46">Liakopoulos et al., 2016</xref>). Mutations at M<sub>69</sub>, S<sub>130</sub>, A<sub>187</sub>, T<sub>235</sub>, and R<sub>244</sub> are known to induce inhibitor resistance in the enzyme (<xref ref-type="bibr" rid="bib66">Pagan-Rodriguez et al., 2004</xref>). In PDC-3, substitutions primarily occur on the Ω-loop, enhancing its flexibility to accommodate the bulky side chains of antibiotics, while deletions are more common in the R2-loop (<xref ref-type="bibr" rid="bib41">Jacoby, 2009</xref>). The predominant Ω-loop mutations isolated from clinics are found at positions V<sub>211</sub>, G<sub>214</sub>, E<sub>219</sub>, and Y<sub>221</sub> (<xref ref-type="bibr" rid="bib5">Barnes et al., 2018</xref>).</p><sec id="s2-1"><title>Emergence of highly conserved dynamic couplings</title><p>DyNoPy builds a pairwise model of conserved dynamic couplings detected by combining coevolution scores and information on functional motions into a score <italic>J<sub>ij</sub></italic> (see ‘Methods’ and <xref ref-type="fig" rid="fig1">Figure 1</xref>). To this end, a dynamic descriptor should be selected. When the descriptor is associated with functional conformational changes, it is expected that functionally relevant couplings will report higher scores. Dynamic descriptors can be selected from commonly used geometrical collective variables (CVs) for the analysis of MD trajectories (see ‘Methods’). As expected, the average <bold><italic>J</italic></bold> matrix score varies across the different CVs, with some of them showing no signal of dynamic coupling (<xref ref-type="fig" rid="fig3">Figure 3A</xref>).</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Features and residues in each community.</title><p>(<bold>A</bold>) Average <italic>J</italic> matrix score varies across different collective variables (CVs). Left: SHV-1; right: PDC-3. (<bold>B</bold>) Number of non-zero couplings detected by scaled coevolution scores (<inline-formula><mml:math id="inf1"><mml:msub><mml:mrow><mml:mi>γ</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>) and <italic>J</italic> values calculated by DyNoPy (<inline-formula><mml:math id="inf2"><mml:msub><mml:mrow><mml:mi>J</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>). (<bold>C</bold>) Number of residues of each community in SHV-1. (<bold>D</bold>) Number of residues of each community in PDC-3. A reasonable residue community should contain at least three residues.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-105005-fig3-v1.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Eigenvector centrality (EVC) distribution of all the residues for each community.</title><p>(<bold>A</bold>) EVC distribution of SHV-1 for each community detected by traditional coevolution scores. (<bold>B</bold>) EVC distribution of PDC-3 of each community detected by traditional coevolution scores. (<bold>C</bold>) EVC distribution of SHV-1 of each community induced from <italic>J</italic> value calculated by DyNoPy. (<bold>D</bold>) EVC distribution of PDC-3 of each community induced from <italic>J</italic> value calculated by DyNoPy.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-105005-fig3-figsupp1-v1.tif"/></fig></fig-group><p>SHV-1 and PDC-3 exhibit distinct dynamics, requiring a different choice of the CV that best captures the functional dynamics. For SHV-1, the global first principal component (PC1) proved to be the most effective feature, identifying 571 residue pairs with a <italic>J<sub>ij</sub></italic> value greater than 0. Conversely, PDC-3 requires selection of more localized features that can extract the Ω-loop dynamics from the overall protein motion. Among the dynamic descriptors, the partial first time-lagged component (TC1_partial) performed best for PDC-3, detecting 216 residue pairs with a <italic>J<sub>ij</sub></italic> value greater than 0. Consequently, PC1 and TC1_partial were selected to build the <bold><italic>J</italic></bold> matrix for SHV-1 and PDC-3, respectively. The performance of all 12 CVs for each protein was assessed and listed in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1b</xref>.</p><p>The importance of dynamical information is evident when coevolution couplings (<inline-formula><mml:math id="inf3"><mml:msub><mml:mrow><mml:mi>γ</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>) and conserved dynamic couplings (<italic>J<sub>ij</sub></italic>) are compared: the number of non-zero couplings decreases from 40% to &lt;2% of total residue pairs in the protein (<xref ref-type="fig" rid="fig3">Figure 3B</xref>) when information from the dynamics descriptor is added. Thus, the inclusion of protein dynamics in coevolution studies acts as an effective filter that rules out residue pairs that do not have significant correlations with functional motions. Moreover, when relying only on <inline-formula><mml:math id="inf4"><mml:msub><mml:mrow><mml:mi>γ</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>, all the residues in SHV-1 and PDC-3 are included within four identified communities (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1c</xref>), suggesting that coevolution scores (<inline-formula><mml:math id="inf5"><mml:msub><mml:mrow><mml:mi>γ</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>) alone do not effectively discriminate residues relevant for protein functions. Furthermore, it would be hard to distinguish critical core residues for each community using only <inline-formula><mml:math id="inf6"><mml:msub><mml:mrow><mml:mi>γ</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> as the eigenvector centrality (EVC) values for the residues do not show remarkable differences (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A and B</xref>). This means that detailed dynamic investigation of the top residues is needed to determine which pairs should be picked up and further analysed. On the other hand, it is much easier to identify essential residues based on <italic>J</italic> scores calculated as clear outliers with significantly higher EVC values could be seen for almost all communities (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1C and D</xref>; <xref ref-type="bibr" rid="bib69">Parente et al., 2015</xref>; <xref ref-type="bibr" rid="bib58">Negre et al., 2018</xref>). In conclusion, the lack of specificity in the statistically based coevolution analysis supports the choice of incorporating a score for the correlation between residue interactions and dynamic behaviours that enables deconvolution of community information.</p><sec id="s2-1-1"><title>DyNoPy reveals critical residues and predicts evolutionary pathways in SHV-1</title><p>DyNoPy identified eight meaningful communities, each consisting of at least three strongly coupled residues within SHV-1 (<xref ref-type="fig" rid="fig3">Figure 3C</xref>). All crucial catalytic residues and critical substitution sites previously mentioned participating in one of these communities with the exceptions of R<sub>43</sub>, R<sub>202</sub>, and S<sub>130</sub>. Residues previously known to have critical role in function or conferring ESBLs/IRBLs phenotype are either directly coupled to protein dynamics or act as a central hub. The hubs interact with residues with either a role in catalysis or structural stability through their membership of hydrophobic nodes (<xref ref-type="bibr" rid="bib64">Olehnovics et al., 2021</xref>). Furthermore, DyNoPy identified key positions (L<sub>162</sub> and N<sub>136</sub>) within some communities that are known to undergo substitutions, conferring an ESBL phenotype in other class A β-lactamases. These substitutions have not yet emerged in the SHV family, providing insightful predictions about the potential future evolution of the enzyme. Detailed discussions of communities with secondary importance for protein function (communities 3, 8, and 9) is provided in the Appendix (<xref ref-type="fig" rid="app2fig1">Appendix 2—figure 1</xref>).</p></sec><sec id="s2-1-2"><title>DyNoPy predicts mutation hotspots in SHV-1</title><p>DyNoPy detects critical mutation sites (L<sub>162</sub> and N<sub>136</sub>) that are known to extend the range of substrates in other class A β-lactamases but have not yet emerged as variants in the SHV family. These sites have not been modified in the SHV family because of their plausible central role within the communities as they are mediating couplings with key functional residues essential for catalytic activity and structural stability, indicating their critical role in protein function and the potential lower mutation rate. These findings provide insightful predictions about the potential future evolution of the enzyme, as well as plausible explanations for why these mutations have not yet appeared.</p><p>L<sub>162,</sub> positioned at the start of the Ω-loop and adjacent to the crucial catalytic residue E<sub>166,</sub> is assigned as the core residue for community 1 (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). While it remains conserved in the SHV family, variants of L<sub>162</sub> have been isolated in other class A β-lactamase and are known to expand the enzyme catalytic spectrum. Single amino acid substitution at L<sub>162</sub> can intensify antibiotic resistance in BEL-1 (<xref ref-type="bibr" rid="bib77">Pozzi et al., 2016</xref>), a class A ESBL clinical variant, exhibiting robust resistance to ticarcillin and ceftazidime (<xref ref-type="bibr" rid="bib12">Bogaerts et al., 2007</xref>). BEL-2 diverges from BEL-1 by single amino acid substitution (L<sub>162</sub>F), which alters the kinetic properties of the enzyme significantly and increases its affinity towards expanded-spectrum cephalosporins (<xref ref-type="bibr" rid="bib74">Poirel et al., 2010</xref>). The relationship between L<sub>162</sub> and protein catalytic functions can be explained using DyNoPy model as there are couplings with catalytic important residues M<sub>69</sub>, K<sub>73</sub>, E<sub>166</sub>, and K<sub>234</sub>. Moreover, the BEL case has confirmed that L<sub>162</sub>F mutation significantly destabilizes the overall protein structure, highlighting the crucial role of L<sub>162</sub> in maintaining protein stability (<xref ref-type="bibr" rid="bib77">Pozzi et al., 2016</xref>). DyNoPy accurately identifies the centrality of L<sub>162</sub> by reporting its connections with 28 backbone residues, including 9 hydrophobic node residues critical for protein stability. Among these, five hydrophobic residues are part of the α2 node: V<sub>75</sub>, L<sub>76</sub>, G<sub>78</sub>, V<sub>80</sub>, and L<sub>81</sub>, highlighting the contribution of L<sub>162</sub> to the stability of the α2 helix (<xref ref-type="bibr" rid="bib64">Olehnovics et al., 2021</xref>).</p><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Communities 1, 4, and 5 of SHV-1 β-lactamase.</title><p>All the residues are depicted as spheres on the protein structure. The core residue for each community is highlighted in red, while purple is used to emphasize the secondary core residue. Residues that interact with both cores are coloured in light yellow. Functional important residues are marked in cyan. Hydrophobic nodes are enclosed with cyan boxes. (A) Community 1 of SHV-1, comprising 33 residues with L<sub>162</sub> being the primary core residue. (B) Community 4 of SHV-1, containing 12 residues and is centred by G<sub>156</sub>. G<sub>156</sub> and A<sub>146</sub> are two functional important residues distant from the active site. G<sub>156</sub> is 21.3 Å away from the catalytic S<sub>70</sub>. A<sub>146</sub> is 16.8 Å away from S<sub>70</sub>. (C) Community 5 of SHV-1, embracing 48 residues and showing a strong correlation between V<sub>103</sub> and S<sub>106</sub>.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-105005-fig4-v1.tif"/></fig><p>Just like L<sub>162</sub>, N<sub>136</sub> undergoes advantageous mutations in other class A β-lactamases while remains highly conserved within the SHV family. It is the core residue for community 7 (<xref ref-type="fig" rid="fig5">Figure 5B</xref>). This residue forms a hydrogen bond with E<sub>166</sub>, stabilizing the Ω-loop (<xref ref-type="bibr" rid="bib13">Bös and Pleiss, 2008</xref>). Although DyNoPy did not detect this direct interaction between N<sub>136</sub> and E<sub>166</sub>, the established relationship between N<sub>136</sub> and N<sub>170</sub> highlights the role of N<sub>136</sub> in influencing E<sub>166</sub>. N<sub>170</sub>, an essential catalytic residue located on the Ω-loop, contributes to priming the water molecule for the deacylation step with E<sub>166</sub> (<xref ref-type="bibr" rid="bib2">Agarwal et al., 2023</xref>), and is directly coupled with N<sub>136</sub>. Due to the essential contribution of N<sub>136</sub> in facilitating E<sub>166</sub> to maintain its proper orientation, it was previously thought to be intolerant to mutations as substitution of asparagine to alanine at this position would make the enzyme lose its function completely (<xref ref-type="bibr" rid="bib19">Cao et al., 2020</xref>). However, N<sub>136</sub>D substitution has emerged as a new clinical variant very recently in PenL, a class A β-lactamase, by increasing its ability in hydrolysing ceftazidime (<xref ref-type="bibr" rid="bib19">Cao et al., 2020</xref>), suggesting that this site has potential to mutate. This gain of function is mainly triggered by the increased flexibility of the Ω-loop (<xref ref-type="bibr" rid="bib19">Cao et al., 2020</xref>). DyNoPy correctly detects a dynamical relationship between N<sub>136</sub> and the Ω-loop (residues 164–179). Six residues present in the Ω-loop participate within this community, including R<sub>164</sub> and D<sub>179</sub>. These two residues are critical as they are forming the ‘bottleneck’ of the Ω-loop which is essential for the correct position of E<sub>166</sub> (<xref ref-type="bibr" rid="bib70">Parwana et al., 2024</xref>). D<sub>179</sub> is also a critical mutation site for SHV-1. Single amino acid substitutions like D<sub>179</sub>A, D<sub>179</sub>N, and D<sub>179</sub>G are enough for the extended spectrum phenotype (<xref ref-type="bibr" rid="bib46">Liakopoulos et al., 2016</xref>).</p><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Communities 6 and 7 of SHV-1 β-lactamase.</title><p>All the residues are depicted as spheres on the protein structure. The core residue for each community is highlighted in red, while purple is used to emphasize the secondary core residue. Residues that interact with both cores are coloured in light yellow. Functional important residues are marked in cyan. (A) Community 6 of SHV-1, comprising 30 residues with Y<sub>105</sub> being the primary core residue. R<sub>205</sub> is a functional important residue that is 20.6 Å away from the active site S<sub>70</sub>. (B) Community 7 of SHV-1, containing 34 residues and is centred by N<sub>136</sub>.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-105005-fig5-v1.tif"/></fig></sec><sec id="s2-1-3"><title>DyNoPy detects residue couplings essential for protein stability</title><p>DyNoPy identifies residue couplings critical for protein functional motions, particularly associated with protein stability. These residue pairs exhibit strong relationships as they are not only directly coupled with each other but also forms various indirect couplings via other residues. As a result, both residues are considered as core residues inside these communities. It is expected that disruption of these couplings through mutation could compromise collective motions essential for enzyme activity.</p><p>As the secondary core residues in community 1 (<xref ref-type="fig" rid="fig4">Figure 4A</xref>), F<sub>72</sub> is showing a strong coupling with the primary core residue L<sub>162</sub> and also forms nine indirect couplings with L<sub>162</sub>, including via the catalytic K<sub>234</sub>. This network of direct and indirect relationships reveals the importance of F<sub>72</sub> and L<sub>162</sub> coupling in maintaining protein functional motions. Interestingly, previous studies identified a small hydrophobic cavity formed by L<sub>162</sub> and F<sub>72</sub>, together with L<sub>139</sub>, and L<sub>148</sub>, which is essential for the stability of the active site (<xref ref-type="bibr" rid="bib77">Pozzi et al., 2016</xref>). Notably, DyNoPy successfully recovers the key residues of this local hydrophobic cavity (L<sub>162</sub>, F<sub>72</sub>, and L<sub>148</sub>).</p><p>The strong interplay between V<sub>103</sub> and S<sub>106</sub>, which are both residues on the α3-α4 loop, is seen in community 5 (<xref ref-type="fig" rid="fig4">Figure 4C</xref>). These residues not only interact with each other directly but are also indirectly coupled via 22 other residues. This community emphasizes the significance of hydrophobic nodes in SHV stability and dynamics. Within the analysed 48 residues, 27 are hydrophobic, out of which 15 residues act as nodes critical for enzyme stabilization. Hydrophobic nodes stabilize their own secondary structures and interconnect to stabilize the overall protein (<xref ref-type="bibr" rid="bib32">Galdadas et al., 2021</xref>). V<sub>103</sub> and S<sub>106</sub> themselves are hydrophobic nodes, stabilizing α3 helix and α4 helix, respectively, and are strongly coupled with each other. In CTX-M, another class A enzyme, N<sub>106</sub>S is a common substitution that results in improved thermodynamic stability and compensate for the loss in stability of the variants (<xref ref-type="bibr" rid="bib49">Lu et al., 2022</xref>). Interestingly, this residue is already a serine in SHV but still implies its pivotal role in protein stability.</p></sec><sec id="s2-1-4"><title>DyNoPy provides valid explanations for mutation sites</title><p>During the evolution of β-lactamases, single mutations on specific sites that are distant from the functional sites have been observed to significantly alter protein catalytic functions. Additionally, single mutations on some surface exposed residues can dramatically increase protein stability. Understanding how these distant mutations impact function and stability becomes a major challenge in understanding protein evolutionary pathways. Communities extracted by DyNoPy show these residues linked with functional important residues, providing a rational for these mutation sites with unknown functions.</p><p>Mutations of G<sub>156</sub> are limited but they lead to ESBL phenotype in the SHV family (<xref ref-type="bibr" rid="bib46">Liakopoulos et al., 2016</xref>). G<sub>156</sub> is the central residue for community 4 (<xref ref-type="fig" rid="fig4">Figure 4B</xref>), but it is distant from the active site, over 20 Å away from the catalytic serine S<sub>70</sub>. Clinical variant SHV-27 has extended resistance ability towards cefotaxime, ceftazidime, and aztreonam (<xref ref-type="bibr" rid="bib24">Corkill et al., 2001</xref>). It differs from SHV-1 by single amino acid substitution G<sub>156</sub>D, suggesting that it has directly evolved from SHV-1 (<xref ref-type="bibr" rid="bib24">Corkill et al., 2001</xref>). Limited research has been done on position G<sub>156</sub>, and the understanding of how it affects the enzyme catalytic properties given that it is far away from the active site is still unclear. Based on our results, we suggest that this residue is essential for the overall protein function because of its 11 coevolved dynamic couplings with protein dynamics, including A<sub>146</sub>, another ESBL substitution site.</p><p>SHV-38, another ESBL that is capable of hydrolysing carbapenems, harbours a single A<sub>146</sub>V substitution compared to SHV-1 (<xref ref-type="bibr" rid="bib73">Poirel et al., 2003</xref>). Like G<sub>156</sub>, A<sub>146</sub> is 16.8 Å away from S<sub>70</sub> but shows an ability in altering protein catalytic function. The A<sub>146</sub>-G<sub>156</sub> residue pair shows a strong coevolutionary signal and strong correlation with protein overall dynamics, implying that there may compensatory mutations at these sites with potential to emerge in the SHV family in the future. These two residues are not connected to any catalytic residues but their coupling to functional dynamics can offer plausible explanation to ESBL activity of these two mutations.</p><p>Unlike other substitution sites that are adjacent to the active site, R<sub>205</sub> is situated more than 20 Å away from catalytic serine S<sub>70</sub>. Its side chain points outwards from the protein, exposing to the solvent. The R<sub>205</sub>L substitution often co-occurs with other ESBL mutations and is thought to indirectly contribute to the ESBL phenotype by compensating for stability loss induced by other mutations (<xref ref-type="bibr" rid="bib6">Ben Achour et al., 2009</xref>). SHV-3 is an ESBL that exhibits significant resistance to cefotaxime and ceftriaxone (<xref ref-type="bibr" rid="bib63">Nicolas et al., 1989</xref>). Two substitutions in this enzyme, R<sub>205</sub>L and G<sub>238</sub>S, extend its resistance profile (<xref ref-type="bibr" rid="bib63">Nicolas et al., 1989</xref>). Thus, it is promising to see that DyNoPy detected these two mutation sites together within community 6 (<xref ref-type="fig" rid="fig5">Figure 5A</xref>).</p><p>Y<sub>105</sub> and R<sub>266</sub> are the core residues for community 6 (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). Y<sub>105</sub> is situated on the α3-α4 loop positioned at the left side of the binding pocket. It is an important catalytic residue that recognizes and binds to the thiazolidine ring of penicillins or β-lactamase inhibitors (<xref ref-type="bibr" rid="bib9">Bethel et al., 2006</xref>). There is very limited information on the role of R<sub>266</sub>, except that it may stabilize the Ω-loop in the SHV family similar to the analogous T<sub>266</sub> in TEM (<xref ref-type="bibr" rid="bib44">Kuzin et al., 1999</xref>). G<sub>238</sub> is coupled with an essential catalytic residue Y<sub>105</sub>, which further links with other catalytic functional residues: S<sub>70</sub> and A<sub>237</sub>, and R<sub>266</sub>, a residue that is known to stabilize the Ω-loop. This indicates that mutations on G<sub>238</sub> would result in an alteration on protein catalytic function, as well as an increased flexibility of the protein, which strongly aligns with previous finding (<xref ref-type="bibr" rid="bib63">Nicolas et al., 1989</xref>). Its linked mutation site R<sub>205</sub> does not show direct coupling with any catalytic residues. Instead, it is directly coupled with R<sub>266,</sub> which we mentioned as an Ω-loop stabilizer. Thus, it is not surprising that R<sub>205</sub> substitution alone is never observed in nature (<xref ref-type="bibr" rid="bib59">Neubauer et al., 2020</xref>) as it would not give significant evolutionary advantage to the protein.</p></sec><sec id="s2-1-5"><title>Insights into the unexplained functional sites of PDC-3</title><p>Unlike the extensively studied SHV-1, the functional roles of individual amino acids in PDC-3 remain largely unexplored. This gap in understanding serves as welcome challenge for interpreting the effects of mutations and the dynamic behaviour of PDC-3 from our results. Although several mutation hotspots, such as those on the Ω-loop (<xref ref-type="bibr" rid="bib5">Barnes et al., 2018</xref>), have been identified, very little is known about the specific contributions of individual amino acids on the functionality of PDC-3.</p><p>In PDC-3, mutations have primarily been reported in the Ω-loop. They enhance its flexibility to accommodate the bulky side chains of antibiotics, while deletions are more common in the R2-loop (<xref ref-type="bibr" rid="bib41">Jacoby, 2009</xref>). DyNoPy detected five communities in total (<xref ref-type="fig" rid="fig3">Figure 3D</xref>), with all the four predominant Ω-loop mutations appearing in these communities. Communities 3, 4 and 5 are discussed in the Appendix (<xref ref-type="fig" rid="app2fig2">Appendix 2—figure 2</xref>). Furthermore, DyNoPy also detected several previously unexplored Ω-loop residues.</p><p>G<sub>214</sub>, a known mutation site in PDC-3, is the core residue in community 1. Another two essential mutation sites, E<sub>219</sub> and Y<sub>221</sub>, also participate in this community, directly coupled with G<sub>214</sub> (<xref ref-type="fig" rid="fig6">Figure 6A</xref>). G<sub>214</sub> also has direct couplings with four other Ω-loop residues: A<sub>195</sub>, A<sub>197</sub>, G<sub>212</sub>, and L<sub>216</sub>. Previous results have demonstrated that substitutions of glycine to alanine or arginine at 214 significantly destabilize the Ω-loop (<xref ref-type="bibr" rid="bib22">Chen et al., 2024</xref>). The strong correlation between G<sub>214</sub> and these Ω-loop residues emphasizes the significant contribution of G<sub>214</sub> towards the stability of the Ω-loop, which corroborates with previous results (<xref ref-type="bibr" rid="bib22">Chen et al., 2024</xref>). Moreover, substitutions such as G<sub>214</sub>A and G<sub>214</sub>R and mutations on E<sub>219</sub> and Y<sub>221</sub> do not affect R2 loop flexibility, resulting in the smaller active site volume among variants (<xref ref-type="bibr" rid="bib22">Chen et al., 2024</xref>) because none of the residues from the R2 loop are detected in this community, offering plausible explanation to the previously unexplained phenomenon.</p><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Communities 1 and 2 of PDC-3 β-lactamase.</title><p>All the residues are depicted as spheres on the protein structure. The core residue for each community is highlighted in red. Functional important residues are marked in cyan. (A) Community 1 of PDC-3, comprising 36 residues with G<sub>214</sub> being the primary core residue. (B) Community 2 of PDC-3, containing 74 residues and is centred by G<sub>204</sub>.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-105005-fig6-v1.tif"/></fig><p>G<sub>204</sub> is the core residue of community 2, coupled with 73 other residues, most of which are distant from the catalytic site, suggesting plausible crucial role in the overall protein stability like L<sub>162</sub> in SHV-1 (<xref ref-type="fig" rid="fig6">Figure 6B</xref>). G<sub>204</sub>, a newly emerged mutation site in the PDC family (67), is located on the short β-sheet β5a within the Ω-loop, near the hinge region between β8 and β9 just above the active site. The only known variant of G<sub>204</sub> is PDC-466, which was derived from PDC-462 (A<sub>89</sub>V, Q<sub>120</sub>K, V<sub>211</sub>A, N<sub>320</sub>S), with an addition of G<sub>204</sub>D (<xref ref-type="bibr" rid="bib23">Colque et al., 2021</xref>). Coupling of G<sub>204</sub> to several catalytically important residues, including K<sub>67</sub>, K<sub>315</sub>, and T<sub>316</sub> can suggest that mutations at this site can negatively impact catalytic power. This offers a plausible explanation of seeing fewer variants at this site, and mutations at this site could have an impact on the hydrolysing capabilities of PDC variants. This should be confirmed by further experimental studies of variants of G<sub>204</sub>. Unlike G<sub>214</sub>, E<sub>219</sub>, and Y<sub>221</sub> mutations which do not influence the dynamics of the R2 loop, substitutions on V<sub>211</sub>, a member of Ω-loop, have an impact on the dynamics of the R2 loop because of its indirect couplings, through G<sub>204</sub> to R2-loop residues (<xref ref-type="bibr" rid="bib22">Chen et al., 2024</xref>). Two less critical substitution sites, H<sub>188</sub> and V<sub>329</sub>, were also observed in community 2.</p></sec></sec><sec id="s2-2"><title>Conclusions</title><p>DyNoPy offers two distinct advantages over existing computational tools (<xref ref-type="bibr" rid="bib91">Yehorova et al., 2024</xref>; <xref ref-type="bibr" rid="bib65">Osuna, 2021</xref>): (a) information on residue–residue coevolution can be directly used to detect the components of protein dynamics that have been preserved during evolution and (b) dynamic descriptors extracted from the MD ensembles can be used to identify the function-specific conserved dynamic couplings. These couplings are then easily modelled as a graph, and network analysis is used to extract epistatic communities and assign roles to residues based on their importance in the graph model. The choice of a relevant descriptor of functional dynamics has an impact on the ability to detect couplings that are involved in functional dynamics.</p><p>Here we demonstrated how the choice of relevant global and local descriptors returns a higher number of effective couplings (greater than 0), and in turn leads to interpretable graph models and communities. In other systems, when multiple descriptors can be used to quantify functional conformational change, it is expected that they will differently modulate the effect of coevolution coupling, which will be reflected in a different structure of the associated graph models. This suggests the use of DyNoPy to generate comparative models in proteins with multiple functions associated to distinct dynamical changes.</p><p>Mutations of L<sub>162</sub> and N<sub>136</sub> have not yet emerged in SHV-1, but they are detected by DyNoPy as core residues for communities. These residues are strongly coupled with other functional important residues, which play critical roles in protein stability and catalytic activity. The identification of these couplings shows high consistency with previous studies and highlights the importance of L<sub>162</sub> and N<sub>136</sub> in SHV-1 functional dynamics. Given their central role in these communities, mutations in L<sub>162</sub> and N<sub>136</sub> can significantly alter protein function, suggesting their potential for future evolutionary changes. However, their strong relationships with these critical functional residues also suggest that mutation at these sites would need to be balanced to maintain protein function, providing an explanation for why such mutations have not yet emerged in SHV-1 (<xref ref-type="bibr" rid="bib85">Soskine and Tawfik, 2010</xref>). The ability of DyNoPy in detecting functionally important mutation sites was demonstrated via well-characterized mutation sites including R<sub>205</sub> and G<sub>238</sub> from SHV-1. Moreover, DyNoPy shows predictive ability on less-studied mutation sites such as G<sub>156</sub> and A<sub>146,</sub> by detecting critical residue couplings that coevolved with functional motions.</p><p>Based on the knowledge we have gained from the analysis of SHV-1 functional protein dynamics, we suggest that in PDC-3, mutations at G<sub>204</sub> because of its significantly conserved dynamic couplings can lead to new ESBL/IRBL clinical variants. We suggest that DyNoPy can be used as a predictive tool to identify potential functional residues within this enzyme and guide future mutagenesis studies.</p><p>In summary, by integrating hidden evolutionary information with direct dynamic interactions, DyNoPy provides a powerful framework for identifying and analysing functional sites in proteins. The tool not only identifies key residues involved in local and global interactions but also improves our ability to predict silent residues with previously unknown roles for future experimental testing. Our application of DyNoPy to broad-spectrum β-lactamases ESBLs and IRBLs demonstrates its potential to address key medical challenges such as antibiotic resistance by providing valid predictions on protein evolution.</p></sec></sec><sec id="s3" sec-type="methods"><title>Methods</title><p>DyNoPy generates a graph representation of the protein structure that captures the couplings between amino acid residues contributing to the functional dynamics of the protein. Residues are represented as graph nodes, and conserved dynamic couplings are recorded as edges. Edge weights quantify the strength of these couplings. The model is built on two assumptions: residue pairs should have (a) coevolved and their (b) time-dependent interactions correlate with a functional conformational change.</p><p>Therefore, edge weights (<inline-formula><mml:math id="inf7"><mml:msub><mml:mrow><mml:mi>J</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>) for residue <inline-formula><mml:math id="inf8"><mml:mi>i</mml:mi></mml:math></inline-formula> and <inline-formula><mml:math id="inf9"><mml:mi>j</mml:mi></mml:math></inline-formula> are calculated as<disp-formula id="equ1"><label>(1)</label><mml:math id="m1"><mml:mrow><mml:msub><mml:mi>J</mml:mi><mml:mrow><mml:mi mathvariant="bold-italic">i</mml:mi><mml:mi mathvariant="bold-italic">j</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mi>α</mml:mi><mml:msub><mml:mi>γ</mml:mi><mml:mrow><mml:mi mathvariant="bold-italic">i</mml:mi><mml:mi mathvariant="bold-italic">j</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mi>β</mml:mi><mml:msub><mml:mi>ρ</mml:mi><mml:mrow><mml:mi mathvariant="bold-italic">i</mml:mi><mml:mi mathvariant="bold-italic">j</mml:mi></mml:mrow></mml:msub><mml:mspace width="thinmathspace"/><mml:mi>w</mml:mi><mml:mi>h</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>α</mml:mi><mml:mo>+</mml:mo><mml:mi>β</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:math></disp-formula></p><p>where <inline-formula><mml:math id="inf10"><mml:msub><mml:mrow><mml:mi>γ</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> is the scaled coevolution score and <inline-formula><mml:math id="inf11"><mml:msub><mml:mrow><mml:mi>ρ</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> is the degree of correlation with the selected functional conformational change. α and β are weights assigned to <inline-formula><mml:math id="inf12"><mml:msub><mml:mrow><mml:mi>γ</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> and <inline-formula><mml:math id="inf13"><mml:msub><mml:mrow><mml:mi>ρ</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> that have a sum of 1. The relative weight of the scaled coevolution score (α) is set to 0.5 in this study. When either of the assumptions listed above is not met, <inline-formula><mml:math id="inf14"><mml:msub><mml:mrow><mml:mi>J</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="bold-italic">i</mml:mi><mml:mi mathvariant="bold-italic">j</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> is set to zero.</p><sec id="s3-1"><title>Scaled coevolution scores</title><p>The occurrence of residue–residue coevolution can be estimated and quantified using probabilistic models of correlated mutations from deep MSA. DyNoPy supports generation of the MSA using the HH-Suite package (<xref ref-type="bibr" rid="bib79">Remmert et al., 2011</xref>) and calculation of scaled coevolution score (<inline-formula><mml:math id="inf15"><mml:msub><mml:mrow><mml:mi>γ</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>) using CCMpred (<xref ref-type="bibr" rid="bib84">Seemayer et al., 2014</xref>) as per the protocol described in <xref ref-type="bibr" rid="bib10">Bibik et al., 2024</xref>. For SHV-1 and PDC-3, hhblits returned 18,174 sequences (N<sub>eff</sub>: 11.082) and 27,892 sequences (N<sub>eff</sub>: 9.951). Sequences were detected from the UniRef30 (v2022_02) database (<xref ref-type="bibr" rid="bib57">Mirdita et al., 2017</xref>). First, a pairwise residue coevolution matrix (<bold><italic>C</italic></bold>) is calculated, then these raw scores (<inline-formula><mml:math id="inf16"><mml:msub><mml:mrow><mml:mi>c</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>) are divided by the matrix mean (<xref ref-type="disp-formula" rid="equ2">Equation 2</xref>). All scores (<inline-formula><mml:math id="inf17"><mml:msub><mml:mrow><mml:mi>s</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>) smaller than 1 are set to zero, and the remaining values are normalized by the maximum value (<xref ref-type="disp-formula" rid="equ3">Equation 3</xref>):<disp-formula id="equ2"><label>(2)</label><mml:math id="m2"><mml:mrow><mml:msub><mml:mi>s</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:msub><mml:mi>c</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:mo>⟨</mml:mo><mml:mi>C</mml:mi><mml:mo>⟩</mml:mo></mml:mrow></mml:mfrac></mml:mrow></mml:math></disp-formula><disp-formula id="equ3"><label>(3)</label><mml:math id="m3"><mml:mrow><mml:msub><mml:mi>γ</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mrow><mml:mo>{</mml:mo><mml:mtable columnalign="left left" rowspacing=".2em" columnspacing="1em" displaystyle="false"><mml:mtr><mml:mtd><mml:mn>0</mml:mn><mml:mo>,</mml:mo></mml:mtd><mml:mtd><mml:msub><mml:mi>s</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>&lt;</mml:mo><mml:mn>1</mml:mn></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mfrac><mml:msub><mml:mi>s</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>s</mml:mi><mml:mrow><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:msub></mml:mfrac><mml:mo>,</mml:mo></mml:mtd><mml:mtd><mml:msub><mml:mi>s</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>≥</mml:mo><mml:mn>1</mml:mn></mml:mtd></mml:mtr></mml:mtable><mml:mo fence="true" stretchy="true" symmetric="true"/></mml:mrow></mml:mrow></mml:math></disp-formula></p></sec><sec id="s3-2"><title>Correlation with functional motions</title><p>The contribution of a residue pair to a selected functional motion is estimated by how much the change in interaction energy between the two residues over time is correlated with a CV describing the functional motion:<disp-formula id="equ4"><label>(4)</label><mml:math id="m4"><mml:mrow><mml:msub><mml:mi>r</mml:mi><mml:mrow><mml:mi mathvariant="bold-italic">i</mml:mi><mml:mi mathvariant="bold-italic">j</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mi>c</mml:mi><mml:mi>o</mml:mi><mml:mi>r</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>ε</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mi>d</mml:mi></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:math></disp-formula><disp-formula id="equ5"><label>(5)</label><mml:math id="m5"><mml:mrow><mml:msub><mml:mi>ρ</mml:mi><mml:mrow><mml:mi mathvariant="bold-italic">i</mml:mi><mml:mi mathvariant="bold-italic">j</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mrow><mml:mo>{</mml:mo><mml:mtable columnalign="left left" rowspacing=".2em" columnspacing="1em" displaystyle="false"><mml:mtr><mml:mtd><mml:mn>0</mml:mn><mml:mo>,</mml:mo></mml:mtd><mml:mtd><mml:msub><mml:mi>r</mml:mi><mml:mrow><mml:mi mathvariant="bold-italic">i</mml:mi><mml:mi mathvariant="bold-italic">j</mml:mi></mml:mrow></mml:msub><mml:mo>≤</mml:mo><mml:mn>0.5</mml:mn></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:msub><mml:mi>r</mml:mi><mml:mrow><mml:mi mathvariant="bold-italic">i</mml:mi><mml:mi mathvariant="bold-italic">j</mml:mi></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>r</mml:mi><mml:mrow><mml:mi mathvariant="bold-italic">i</mml:mi><mml:mi mathvariant="bold-italic">j</mml:mi></mml:mrow></mml:msub><mml:mo>&gt;</mml:mo><mml:mn>0.5</mml:mn></mml:mtd></mml:mtr></mml:mtable><mml:mo fence="true" stretchy="true" symmetric="true"/></mml:mrow></mml:mrow></mml:math></disp-formula></p><p>where <inline-formula><mml:math id="inf18"><mml:msub><mml:mrow><mml:mi>ε</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mfenced separators="|"><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:mfenced></mml:math></inline-formula> is the pairwise non-bonded interaction energy (see details in Appendix 1) and <inline-formula><mml:math id="inf19"><mml:mi>d</mml:mi><mml:mfenced separators="|"><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:mfenced></mml:math></inline-formula> is the time-dependent value of the CV. Examples of CV and a discussion on the choice of the most relevant CV are presented in the ‘Results’ section. Correlation values smaller than 0.5 are set to 0. In the absence of detectable contributions to the functional dynamics of the system, the couplings extracted by DyNoPy will describe a pure evolutionary model, and the community detection method presented below will be equivalent to a direct decomposition of the residue coevolution network into units.</p></sec><sec id="s3-3"><title>Graph representation and analysis of conserved dynamic couplings</title><p>All pairwise conserved dynamic couplings (<xref ref-type="disp-formula" rid="equ1">Equation 1</xref>) are collected into a square matrix <bold><italic>J</italic></bold>. A graph is built from <bold><italic>J</italic></bold> using python-igraph v0.11 library (<xref ref-type="bibr" rid="bib25">Csárdi and Nepusz, 2006</xref>). Nodes represent residues, and edges are drawn between nodes with positive <inline-formula><mml:math id="inf20"><mml:msub><mml:mrow><mml:mi>J</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="bold-italic">i</mml:mi><mml:mi mathvariant="bold-italic">j</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>. Edge weights are set to <inline-formula><mml:math id="inf21"><mml:msub><mml:mrow><mml:mi>J</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="bold-italic">i</mml:mi><mml:mi mathvariant="bold-italic">j</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>. The relative importance of the residues in this model of protein dynamics is calculated as EVC of the nodes (<xref ref-type="bibr" rid="bib61">Newman, 2004</xref>). The residues involved in extensive correlated dynamics with other highly connected residues have higher EVC scores. Groups of residues contributing to important collective motions are detected by community analysis of the graph structure. The Girvan–Newman algorithm is used to extract the community structure (<xref ref-type="bibr" rid="bib62">Newman, 2006</xref>). A meaningful community should contain at least three residues. Applying network analysis on the combined dynamics-coevolution matrix helps us extract higher-order interactions beyond pairwise coupling and detecting critical residues, which show multiple interactions with each other. Moreover, indirect long-range relationships, which would be hard to identify from numerical data, could be detected through community clustering. Community-based analysis offers a more comprehensive understanding of residue relationships and enables the visualization of residue couplings on the protein structure.</p></sec><sec id="s3-4"><title>Adaptive sampling molecular dynamics simulations</title><p>MD simulation data was sourced from our previous studies (<xref ref-type="bibr" rid="bib64">Olehnovics et al., 2021</xref>; <xref ref-type="bibr" rid="bib22">Chen et al., 2024</xref>). To summarize, SHV-1 structural coordinates (PDB ID: 3N4I) were obtained from the Protein Data Bank and modified to the wild type by introducing the E104D mutation. Similarly, the PDC-3 structure was derived from PDC-1 (PDB ID: 4HEF) by a T105A substitution. Both enzymes were protonated at pH 7.0 using PropKa from the PlayMolecule platform (<xref ref-type="bibr" rid="bib52">Martínez-Rosell et al., 2017</xref>). One disulfide bond between C<sub>77</sub> and C<sub>123</sub> was specified in SHV-1. Both structures were solvated with TIP3P water molecules in a periodic box with a box size of 10 Å. Ions were added to neutralize the overall charge of each system at 150 mM KCl. Amber force field ff14SB was used for all MD simulations (<xref ref-type="bibr" rid="bib50">Maier et al., 2015</xref>). After an initial minimization of 1000 steps, both the enzymes were equilibrated for 5 ns in the NPT ensemble at 1 atmospheric pressure using the Berendsen barostat (<xref ref-type="bibr" rid="bib7">Berendsen et al., 1984</xref>). The initial velocities for each simulation were sampled from the Boltzmann distribution at 300 K. Multiple Markov state model (MSM)-based adaptively sampled simulations were performed for both proteins based on the ACEMD engine (<xref ref-type="bibr" rid="bib28">Doerr et al., 2016</xref>; <xref ref-type="bibr" rid="bib36">Harvey et al., 2009</xref>). A canonical (NVT) ensemble with a Langevin thermostat (<xref ref-type="bibr" rid="bib26">Davidchack et al., 2009</xref>) (damping coefficient of 0.1 ps−1) and a hydrogen mass repartitioning scheme were employed to achieve time steps of 4 fs. For SHV-1, each trajectory spanned 60 ns with a time step of 0.1 ns, with a total of 593 trajectories. In the case of PDC-3, 100 trajectories were collected, each containing 3000 frames, lasting 300 ns. To manage the extensive datasets efficiently, trajectories were strategically stridden to ensure that a minimum of 30,000 frames were preserved for each system. The resulting trajectories are summarized in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1d</xref>.</p></sec><sec id="s3-5"><title>Calculation and selection of collective variables</title><p>DyNoPy works on the assumption that time-dependent interactions between critical residues, either having significant structural change or not, will correlate with functional conformational motions. Since MD simulation data is high-dimensional, a time-dependent CV is required to extract the most relevant information for the process under study. The usefulness of DyNoPy is dependent on the choice of the CVs. To guide the selection of CVs, we selected 12 distinct features: radius of gyration (R<sub>g</sub>), the first principal component (PC1), partial PC1 (PC1_partial), the first time-lagged independent component (TC1), partial TC1 (TC1_partial), global root mean square deviation (gRMSD), partial RMSD (pRMSD), dynamical RMSD (dRMSD), global solvent-accessible surface area (gSASA), partial SASA (pSASA), active site pocket volume, and the number of hydrogen bonds (hbond). A description of the CVs, including the calculation methods and the residues used to calculate the partial variables, is detailed in Appendix 1. CVs were subsequently used as input features for DyNoPy. A good CV should appropriately describe protein functional motions. Thus, a CV that detects the highest number of residue couplings is expected to be the most suitable descriptor. The length of the MD simulations should be appropriate to effectively sample the desired functional process as described by the selected CV.</p></sec></sec></body><back><sec sec-type="additional-information" id="s4"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn><fn fn-type="COI-statement" id="conf2"><p>Reviewing editor, eLife</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Formal analysis, Validation, Investigation, Visualization, Writing - original draft</p></fn><fn fn-type="con" id="con2"><p>Conceptualization, Software, Formal analysis, Validation, Investigation, Visualization, Methodology, Writing - original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con3"><p>Conceptualization, Investigation, Writing – review and editing</p></fn><fn fn-type="con" id="con4"><p>Validation, Project administration, Writing – review and editing</p></fn><fn fn-type="con" id="con5"><p>Conceptualization, Software, Formal analysis, Supervision, Validation, Investigation, Visualization, Methodology, Project administration, Writing – review and editing</p></fn><fn fn-type="con" id="con6"><p>Conceptualization, Resources, Formal analysis, Supervision, Validation, Investigation, Visualization, Methodology, Project administration, Writing – review and editing</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s5"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>Features, descriptors and protocol summary.</title><p>(<bold>a</bold>) Hydrophobic nodes in SHV-1. (<bold>b</bold>) Dynamic descriptors and number of residue pairs detected. (<bold>c</bold>) Number of residues in each community detected using only the coevolution scores. (<bold>d</bold>) Summary of molecular dynamics simulation systems.</p></caption><media xlink:href="elife-105005-supp1-v1.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-105005-mdarchecklist1-v1.docx" mimetype="application" mime-subtype="docx"/></supplementary-material></sec><sec sec-type="data-availability" id="s6"><title>Data availability</title><p>All files required to run the simulations (topology, coordinates, input), processed trajectories (xtc), corresponding coordinates (pdb), can be downloaded from <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.57760/sciencedb.15876">https://doi.org/10.57760/sciencedb.15876</ext-link> (PDC-3) and <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.5281/zenodo.13693144">https://doi.org/10.5281/zenodo.13693144</ext-link> (SHV-1). DyNoPy is available at <ext-link ext-link-type="uri" xlink:href="https://github.com/alepandini/DyNoPy">https://github.com/alepandini/DyNoPy</ext-link>, (copy archived at <xref ref-type="bibr" rid="bib68">Pandini, 2024</xref>).</p><p>The following previously published datasets were used:</p><p><element-citation publication-type="data" specific-use="references" id="dataset1"><person-group person-group-type="author"><name><surname>Haider</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2024">2024</year><data-title>Ω-Loop mutations control the dynamics of the active site by modulating a network of hydrogen bonds in PDC-3 β-lactamase</data-title><source>Science Data Bank</source><pub-id pub-id-type="doi">10.57760/sciencedb.15876</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset2"><person-group person-group-type="author"><name><surname>Haider</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2024">2024</year><data-title>Functionally Important Residues from Graph Analysis of Co-evolved Dynamical Couplings</data-title><source>Zenodo</source><pub-id pub-id-type="doi">10.5281/zenodo.13693144</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>SCD was supported by Leverhulme Trust grant RPG-2017-222 awarded to AP and JAG. The authors would like to thank Arianna Fornili for insightful suggestions on the design of DyNoPy methodology.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abraham</surname><given-names>MJ</given-names></name><name><surname>Murtola</surname><given-names>T</given-names></name><name><surname>Schulz</surname><given-names>R</given-names></name><name><surname>Páll</surname><given-names>S</given-names></name><name><surname>Smith</surname><given-names>JC</given-names></name><name><surname>Hess</surname><given-names>B</given-names></name><name><surname>Lindahl</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers</article-title><source>SoftwareX</source><volume>1–2</volume><fpage>19</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1016/j.softx.2015.06.001</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agarwal</surname><given-names>V</given-names></name><name><surname>Yadav</surname><given-names>TC</given-names></name><name><surname>Tiwari</surname><given-names>A</given-names></name><name><surname>Varadwaj</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Detailed investigation of catalytically important residues of class A β-lactamase</article-title><source>Journal of Biomolecular Structure &amp; Dynamics</source><volume>41</volume><fpage>2046</fpage><lpage>2073</lpage><pub-id pub-id-type="doi">10.1080/07391102.2021.2023645</pub-id><pub-id pub-id-type="pmid">34986744</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ambler</surname><given-names>RP</given-names></name><name><surname>Coulson</surname><given-names>AF</given-names></name><name><surname>Frère</surname><given-names>JM</given-names></name><name><surname>Ghuysen</surname><given-names>JM</given-names></name><name><surname>Joris</surname><given-names>B</given-names></name><name><surname>Forsman</surname><given-names>M</given-names></name><name><surname>Levesque</surname><given-names>RC</given-names></name><name><surname>Tiraby</surname><given-names>G</given-names></name><name><surname>Waley</surname><given-names>SG</given-names></name></person-group><year iso-8601-date="1991">1991</year><article-title>A standard numbering scheme for the class A beta-lactamases</article-title><source>The Biochemical Journal</source><volume>276 (Pt 1)</volume><fpage>269</fpage><lpage>270</lpage><pub-id pub-id-type="doi">10.1042/bj2760269</pub-id><pub-id pub-id-type="pmid">2039479</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baek</surname><given-names>M</given-names></name><name><surname>DiMaio</surname><given-names>F</given-names></name><name><surname>Anishchenko</surname><given-names>I</given-names></name><name><surname>Dauparas</surname><given-names>J</given-names></name><name><surname>Ovchinnikov</surname><given-names>S</given-names></name><name><surname>Lee</surname><given-names>GR</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Cong</surname><given-names>Q</given-names></name><name><surname>Kinch</surname><given-names>LN</given-names></name><name><surname>Schaeffer</surname><given-names>RD</given-names></name><name><surname>Millán</surname><given-names>C</given-names></name><name><surname>Park</surname><given-names>H</given-names></name><name><surname>Adams</surname><given-names>C</given-names></name><name><surname>Glassman</surname><given-names>CR</given-names></name><name><surname>DeGiovanni</surname><given-names>A</given-names></name><name><surname>Pereira</surname><given-names>JH</given-names></name><name><surname>Rodrigues</surname><given-names>AV</given-names></name><name><surname>van Dijk</surname><given-names>AA</given-names></name><name><surname>Ebrecht</surname><given-names>AC</given-names></name><name><surname>Opperman</surname><given-names>DJ</given-names></name><name><surname>Sagmeister</surname><given-names>T</given-names></name><name><surname>Buhlheller</surname><given-names>C</given-names></name><name><surname>Pavkov-Keller</surname><given-names>T</given-names></name><name><surname>Rathinaswamy</surname><given-names>MK</given-names></name><name><surname>Dalwadi</surname><given-names>U</given-names></name><name><surname>Yip</surname><given-names>CK</given-names></name><name><surname>Burke</surname><given-names>JE</given-names></name><name><surname>Garcia</surname><given-names>KC</given-names></name><name><surname>Grishin</surname><given-names>NV</given-names></name><name><surname>Adams</surname><given-names>PD</given-names></name><name><surname>Read</surname><given-names>RJ</given-names></name><name><surname>Baker</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Accurate prediction of protein structures and interactions using a three-track neural network</article-title><source>Science</source><volume>373</volume><fpage>871</fpage><lpage>876</lpage><pub-id pub-id-type="doi">10.1126/science.abj8754</pub-id><pub-id pub-id-type="pmid">34282049</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barnes</surname><given-names>MD</given-names></name><name><surname>Taracila</surname><given-names>MA</given-names></name><name><surname>Rutter</surname><given-names>JD</given-names></name><name><surname>Bethel</surname><given-names>CR</given-names></name><name><surname>Galdadas</surname><given-names>I</given-names></name><name><surname>Hujer</surname><given-names>AM</given-names></name><name><surname>Caselli</surname><given-names>E</given-names></name><name><surname>Prati</surname><given-names>F</given-names></name><name><surname>Dekker</surname><given-names>JP</given-names></name><name><surname>Papp-Wallace</surname><given-names>KM</given-names></name><name><surname>Haider</surname><given-names>S</given-names></name><name><surname>Bonomo</surname><given-names>RA</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Deciphering the evolution of cephalosporin resistance to ceftolozane-tazobactam in <italic>Pseudomonas aeruginosa</italic></article-title><source>mBio</source><volume>9</volume><elocation-id>e02085-18</elocation-id><pub-id pub-id-type="doi">10.1128/mBio.02085-18</pub-id><pub-id pub-id-type="pmid">30538183</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ben Achour</surname><given-names>N</given-names></name><name><surname>Mercuri</surname><given-names>PS</given-names></name><name><surname>Ben Moussa</surname><given-names>M</given-names></name><name><surname>Galleni</surname><given-names>M</given-names></name><name><surname>Belhadj</surname><given-names>O</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Characterization of a novel extended-spectrum TEM-type beta-lactamase, TEM-164, in a clinical strain of Klebsiella pneumoniae in Tunisia</article-title><source>Microbial Drug Resistance</source><volume>15</volume><fpage>195</fpage><lpage>199</lpage><pub-id pub-id-type="doi">10.1089/mdr.2009.0900</pub-id><pub-id pub-id-type="pmid">19728777</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berendsen</surname><given-names>HJC</given-names></name><name><surname>Postma</surname><given-names>JPM</given-names></name><name><surname>van Gunsteren</surname><given-names>WF</given-names></name><name><surname>DiNola</surname><given-names>A</given-names></name><name><surname>Haak</surname><given-names>JR</given-names></name></person-group><year iso-8601-date="1984">1984</year><article-title>Molecular dynamics with coupling to an external bath</article-title><source>The Journal of Chemical Physics</source><volume>81</volume><fpage>3684</fpage><lpage>3690</lpage><pub-id pub-id-type="doi">10.1063/1.448118</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berrazeg</surname><given-names>M</given-names></name><name><surname>Jeannot</surname><given-names>K</given-names></name><name><surname>Ntsogo Enguéné</surname><given-names>VY</given-names></name><name><surname>Broutin</surname><given-names>I</given-names></name><name><surname>Loeffert</surname><given-names>S</given-names></name><name><surname>Fournier</surname><given-names>D</given-names></name><name><surname>Plésiat</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Mutations in β-Lactamase AmpC Increase resistance of <italic>Pseudomonas aeruginosa</italic> isolates to antipseudomonal cephalosporins</article-title><source>Antimicrobial Agents and Chemotherapy</source><volume>59</volume><fpage>6248</fpage><lpage>6255</lpage><pub-id pub-id-type="doi">10.1128/AAC.00825-15</pub-id><pub-id pub-id-type="pmid">26248364</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bethel</surname><given-names>CR</given-names></name><name><surname>Hujer</surname><given-names>AM</given-names></name><name><surname>Hujer</surname><given-names>KM</given-names></name><name><surname>Thomson</surname><given-names>JM</given-names></name><name><surname>Ruszczycky</surname><given-names>MW</given-names></name><name><surname>Anderson</surname><given-names>VE</given-names></name><name><surname>Pusztai-Carey</surname><given-names>M</given-names></name><name><surname>Taracila</surname><given-names>M</given-names></name><name><surname>Helfand</surname><given-names>MS</given-names></name><name><surname>Bonomo</surname><given-names>RA</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Role of Asp104 in the SHV β-Lactamase</article-title><source>Antimicrobial Agents and Chemotherapy</source><volume>50</volume><fpage>4124</fpage><lpage>4131</lpage><pub-id pub-id-type="doi">10.1128/AAC.00848-06</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bibik</surname><given-names>P</given-names></name><name><surname>Alibai</surname><given-names>S</given-names></name><name><surname>Pandini</surname><given-names>A</given-names></name><name><surname>Dantu</surname><given-names>SC</given-names></name></person-group><year iso-8601-date="2024">2024</year><article-title>PyCoM: a python library for large-scale analysis of residue-residue coevolution data</article-title><source>Bioinformatics</source><volume>40</volume><elocation-id>btae166</elocation-id><pub-id pub-id-type="doi">10.1093/bioinformatics/btae166</pub-id><pub-id pub-id-type="pmid">38532297</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blaabjerg</surname><given-names>LM</given-names></name><name><surname>Kassem</surname><given-names>MM</given-names></name><name><surname>Good</surname><given-names>LL</given-names></name><name><surname>Jonsson</surname><given-names>N</given-names></name><name><surname>Cagiada</surname><given-names>M</given-names></name><name><surname>Johansson</surname><given-names>KE</given-names></name><name><surname>Boomsma</surname><given-names>W</given-names></name><name><surname>Stein</surname><given-names>A</given-names></name><name><surname>Lindorff-Larsen</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Rapid protein stability prediction using deep learning representations</article-title><source>eLife</source><volume>12</volume><elocation-id>e82593</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.82593</pub-id><pub-id pub-id-type="pmid">37184062</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bogaerts</surname><given-names>P</given-names></name><name><surname>Bauraing</surname><given-names>C</given-names></name><name><surname>Deplano</surname><given-names>A</given-names></name><name><surname>Glupczynski</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Emergence and dissemination of BEL-1-producing <italic>Pseudomonas aeruginosa</italic> isolates in Belgium</article-title><source>Antimicrobial Agents and Chemotherapy</source><volume>51</volume><fpage>1584</fpage><lpage>1585</lpage><pub-id pub-id-type="doi">10.1128/AAC.01603-06</pub-id><pub-id pub-id-type="pmid">17261629</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bös</surname><given-names>F</given-names></name><name><surname>Pleiss</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Conserved water molecules stabilize the Omega-loop in class A beta-lactamases</article-title><source>Antimicrobial Agents and Chemotherapy</source><volume>52</volume><fpage>1072</fpage><lpage>1079</lpage><pub-id pub-id-type="doi">10.1128/AAC.01035-07</pub-id><pub-id pub-id-type="pmid">18195065</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Broom</surname><given-names>A</given-names></name><name><surname>Trainor</surname><given-names>K</given-names></name><name><surname>Jacobi</surname><given-names>Z</given-names></name><name><surname>Meiering</surname><given-names>EM</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Computational modeling of protein stability: quantitative analysis reveals solutions to pervasive problems</article-title><source>Structure</source><volume>28</volume><fpage>717</fpage><lpage>726</lpage><pub-id pub-id-type="doi">10.1016/j.str.2020.04.003</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bush</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Proliferation and significance of clinically relevant β-lactamases</article-title><source>Annals of the New York Academy of Sciences</source><volume>1277</volume><fpage>84</fpage><lpage>90</lpage><pub-id pub-id-type="doi">10.1111/nyas.12023</pub-id><pub-id pub-id-type="pmid">23346859</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bush</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Past and present perspectives on β-lactamases</article-title><source>Antimicrobial Agents and Chemotherapy</source><volume>62</volume><elocation-id>e01076-18</elocation-id><pub-id pub-id-type="doi">10.1128/AAC.01076-18</pub-id><pub-id pub-id-type="pmid">30061284</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cagiada</surname><given-names>M</given-names></name><name><surname>Bottaro</surname><given-names>S</given-names></name><name><surname>Lindemose</surname><given-names>S</given-names></name><name><surname>Schenstrøm</surname><given-names>SM</given-names></name><name><surname>Stein</surname><given-names>A</given-names></name><name><surname>Hartmann-Petersen</surname><given-names>R</given-names></name><name><surname>Lindorff-Larsen</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Discovering functionally important sites in proteins</article-title><source>Nature Communications</source><volume>14</volume><elocation-id>4175</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-023-39909-0</pub-id><pub-id pub-id-type="pmid">37443362</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Campitelli</surname><given-names>P</given-names></name><name><surname>Modi</surname><given-names>T</given-names></name><name><surname>Kumar</surname><given-names>S</given-names></name><name><surname>Ozkan</surname><given-names>SB</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The role of conformational dynamics and allostery in modulating protein evolution</article-title><source>Annual Review of Biophysics</source><volume>49</volume><fpage>267</fpage><lpage>288</lpage><pub-id pub-id-type="doi">10.1146/annurev-biophys-052118-115517</pub-id><pub-id pub-id-type="pmid">32075411</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>T-P</given-names></name><name><surname>Yi</surname><given-names>H</given-names></name><name><surname>Dhanasingh</surname><given-names>I</given-names></name><name><surname>Ghosh</surname><given-names>S</given-names></name><name><surname>Choi</surname><given-names>JM</given-names></name><name><surname>Lee</surname><given-names>KH</given-names></name><name><surname>Ryu</surname><given-names>S</given-names></name><name><surname>Kim</surname><given-names>HS</given-names></name><name><surname>Lee</surname><given-names>SH</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Non-catalytic-region mutations conferring transition of class a β-lactamases into ESBLs</article-title><source>Frontiers in Molecular Biosciences</source><volume>7</volume><elocation-id>598998</elocation-id><pub-id pub-id-type="doi">10.3389/fmolb.2020.598998</pub-id><pub-id pub-id-type="pmid">33335913</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>FY</given-names></name><name><surname>Siu</surname><given-names>LK</given-names></name><name><surname>Fung</surname><given-names>CP</given-names></name><name><surname>Huang</surname><given-names>MH</given-names></name><name><surname>Ho</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Diversity of SHV and TEM beta-lactamases in Klebsiella pneumoniae: gene evolution in Northern Taiwan and two novel beta-lactamases, SHV-25 and SHV-26</article-title><source>Antimicrobial Agents and Chemotherapy</source><volume>45</volume><fpage>2407</fpage><lpage>2413</lpage><pub-id pub-id-type="doi">10.1128/AAC.45.9.2407-2413.2001</pub-id><pub-id pub-id-type="pmid">11502506</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Z</given-names></name><name><surname>Rappert</surname><given-names>S</given-names></name><name><surname>Sun</surname><given-names>J</given-names></name><name><surname>Zeng</surname><given-names>AP</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Integrating molecular dynamics and co-evolutionary analysis for reliable target prediction and deregulation of the allosteric inhibition of aspartokinase for amino acid production</article-title><source>Journal of Biotechnology</source><volume>154</volume><fpage>248</fpage><lpage>254</lpage><pub-id pub-id-type="doi">10.1016/j.jbiotec.2011.05.005</pub-id><pub-id pub-id-type="pmid">21609739</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Mack</surname><given-names>AR</given-names></name><name><surname>Hujer</surname><given-names>AM</given-names></name><name><surname>Bethel</surname><given-names>CR</given-names></name><name><surname>Bonomo</surname><given-names>RA</given-names></name><name><surname>Haider</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2024">2024</year><article-title>Ω-Loop Mutations Control the Dynamics of the Active Site by Modulating a Network of Hydrogen Bonds in PDC-3 β-Lactamase</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/2024.02.04.578824</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Colque</surname><given-names>CA</given-names></name><name><surname>Tomatis</surname><given-names>PE</given-names></name><name><surname>Albarracín Orio</surname><given-names>AG</given-names></name><name><surname>Dotta</surname><given-names>G</given-names></name><name><surname>Moreno</surname><given-names>DM</given-names></name><name><surname>Hedemann</surname><given-names>LG</given-names></name><name><surname>Hickman</surname><given-names>RA</given-names></name><name><surname>Sommer</surname><given-names>LM</given-names></name><name><surname>Feliziani</surname><given-names>S</given-names></name><name><surname>Moyano</surname><given-names>AJ</given-names></name><name><surname>Bonomo</surname><given-names>RA</given-names></name><name><surname>Johansen</surname><given-names>HK</given-names></name><name><surname>Molin</surname><given-names>S</given-names></name><name><surname>Vila</surname><given-names>AJ</given-names></name><name><surname>Smania</surname><given-names>AM</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Development of antibiotic resistance reveals diverse evolutionary pathways to face the complex and dynamic environment of a long-term treated patient</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/2021.05.14.444257</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Corkill</surname><given-names>JE</given-names></name><name><surname>Cuevas</surname><given-names>LE</given-names></name><name><surname>Gurgel</surname><given-names>RQ</given-names></name><name><surname>Greensill</surname><given-names>J</given-names></name><name><surname>Hart</surname><given-names>CA</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>SHV-27, a novel cefotaxime-hydrolysing beta-lactamase, identified in Klebsiella pneumoniae isolates from a Brazilian hospital</article-title><source>The Journal of Antimicrobial Chemotherapy</source><volume>47</volume><fpage>463</fpage><lpage>465</lpage><pub-id pub-id-type="doi">10.1093/jac/47.4.463</pub-id><pub-id pub-id-type="pmid">11266422</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Csárdi</surname><given-names>G</given-names></name><name><surname>Nepusz</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2006">2006</year><source>The Igraph Software Package for Complex Network Research</source><publisher-name>Semantic Scholar</publisher-name></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davidchack</surname><given-names>RL</given-names></name><name><surname>Handel</surname><given-names>R</given-names></name><name><surname>Tretyakov</surname><given-names>MV</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Langevin thermostat for rigid body dynamics</article-title><source>The Journal of Chemical Physics</source><volume>130</volume><elocation-id>234101</elocation-id><pub-id pub-id-type="doi">10.1063/1.3149788</pub-id><pub-id pub-id-type="pmid">19548705</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ding</surname><given-names>D</given-names></name><name><surname>Shaw</surname><given-names>AY</given-names></name><name><surname>Sinai</surname><given-names>S</given-names></name><name><surname>Rollins</surname><given-names>N</given-names></name><name><surname>Prywes</surname><given-names>N</given-names></name><name><surname>Savage</surname><given-names>DF</given-names></name><name><surname>Laub</surname><given-names>MT</given-names></name><name><surname>Marks</surname><given-names>DS</given-names></name></person-group><year iso-8601-date="2024">2024</year><article-title>Protein design using structure-based residue preferences</article-title><source>Nature Communications</source><volume>15</volume><elocation-id>1639</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-024-45621-4</pub-id><pub-id pub-id-type="pmid">38388493</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doerr</surname><given-names>S</given-names></name><name><surname>Harvey</surname><given-names>MJ</given-names></name><name><surname>Noé</surname><given-names>F</given-names></name><name><surname>De Fabritiis</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>HTMD: high-throughput molecular dynamics for molecular discovery</article-title><source>Journal of Chemical Theory and Computation</source><volume>12</volume><fpage>1845</fpage><lpage>1852</lpage><pub-id pub-id-type="doi">10.1021/acs.jctc.6b00049</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dunham</surname><given-names>AS</given-names></name><name><surname>Beltrao</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Exploring amino acid functions in a deep mutational landscape</article-title><source>Molecular Systems Biology</source><volume>17</volume><elocation-id>e10305</elocation-id><pub-id pub-id-type="doi">10.15252/msb.202110305</pub-id><pub-id pub-id-type="pmid">34292650</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Estabrook</surname><given-names>RA</given-names></name><name><surname>Luo</surname><given-names>J</given-names></name><name><surname>Purdy</surname><given-names>MM</given-names></name><name><surname>Sharma</surname><given-names>V</given-names></name><name><surname>Weakliem</surname><given-names>P</given-names></name><name><surname>Bruice</surname><given-names>TC</given-names></name><name><surname>Reich</surname><given-names>NO</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Statistical coevolution analysis and molecular dynamics: identification of amino acid pairs essential for catalysis</article-title><source>PNAS</source><volume>102</volume><fpage>994</fpage><lpage>999</lpage><pub-id pub-id-type="doi">10.1073/pnas.0409128102</pub-id><pub-id pub-id-type="pmid">15657135</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galdadas</surname><given-names>I</given-names></name><name><surname>Lovera</surname><given-names>S</given-names></name><name><surname>Pérez-Hernández</surname><given-names>G</given-names></name><name><surname>Barnes</surname><given-names>MD</given-names></name><name><surname>Healy</surname><given-names>J</given-names></name><name><surname>Afsharikho</surname><given-names>H</given-names></name><name><surname>Woodford</surname><given-names>N</given-names></name><name><surname>Bonomo</surname><given-names>RA</given-names></name><name><surname>Gervasio</surname><given-names>FL</given-names></name><name><surname>Haider</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Defining the architecture of KPC-2 Carbapenemase: identifying allosteric networks to fight antibiotics resistance</article-title><source>Scientific Reports</source><volume>8</volume><elocation-id>12916</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-018-31176-0</pub-id><pub-id pub-id-type="pmid">30150677</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galdadas</surname><given-names>I</given-names></name><name><surname>Qu</surname><given-names>S</given-names></name><name><surname>Oliveira</surname><given-names>ASF</given-names></name><name><surname>Olehnovics</surname><given-names>E</given-names></name><name><surname>Mack</surname><given-names>AR</given-names></name><name><surname>Mojica</surname><given-names>MF</given-names></name><name><surname>Agarwal</surname><given-names>PK</given-names></name><name><surname>Tooke</surname><given-names>CL</given-names></name><name><surname>Gervasio</surname><given-names>FL</given-names></name><name><surname>Spencer</surname><given-names>J</given-names></name><name><surname>Bonomo</surname><given-names>RA</given-names></name><name><surname>Mulholland</surname><given-names>AJ</given-names></name><name><surname>Haider</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Allosteric communication in class A β-lactamases occurs via cooperative coupling of loop dynamics</article-title><source>eLife</source><volume>10</volume><elocation-id>e66567</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.66567</pub-id><pub-id pub-id-type="pmid">33755013</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giakkoupi</surname><given-names>P</given-names></name><name><surname>Tzelepi</surname><given-names>E</given-names></name><name><surname>Legakis</surname><given-names>NJ</given-names></name><name><surname>Tzouvelekis</surname><given-names>LS</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Substitution of Arg-244 by Cys or Ser in SHV-1 and SHV-5 beta-lactamases confers resistance to mechanism-based inhibitors and reduces catalytic efficiency of the enzymes</article-title><source>FEMS Microbiology Letters</source><volume>160</volume><fpage>49</fpage><lpage>54</lpage><pub-id pub-id-type="doi">10.1111/j.1574-6968.1998.tb12889.x</pub-id><pub-id pub-id-type="pmid">9495011</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="confproc"><person-group person-group-type="author"><name><surname>Gowers</surname><given-names>R</given-names></name><name><surname>Linke</surname><given-names>M</given-names></name><name><surname>Barnoud</surname><given-names>J</given-names></name><name><surname>Reddy</surname><given-names>T</given-names></name><name><surname>Melo</surname><given-names>M</given-names></name><name><surname>Seyler</surname><given-names>S</given-names></name><name><surname>Domański</surname><given-names>J</given-names></name><name><surname>Dotson</surname><given-names>D</given-names></name><name><surname>Buchoux</surname><given-names>S</given-names></name><name><surname>Kenney</surname><given-names>I</given-names></name><name><surname>Beckstein</surname><given-names>O</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>MDAnalysis: A Python Package for the Rapid Analysis of Molecular Dynamics Simulations</article-title><conf-name>Python in Science Conference</conf-name><pub-id pub-id-type="doi">10.25080/Majora-629e541a-00e</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Granata</surname><given-names>D</given-names></name><name><surname>Ponzoni</surname><given-names>L</given-names></name><name><surname>Micheletti</surname><given-names>C</given-names></name><name><surname>Carnevale</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Patterns of coevolving amino acids unveil structural and dynamical domains</article-title><source>PNAS</source><volume>114</volume><fpage>E10612</fpage><lpage>E10621</lpage><pub-id pub-id-type="doi">10.1073/pnas.1712021114</pub-id><pub-id pub-id-type="pmid">29183970</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harvey</surname><given-names>MJ</given-names></name><name><surname>Giupponi</surname><given-names>G</given-names></name><name><surname>Fabritiis</surname><given-names>GD</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>ACEMD: accelerating biomolecular dynamics in the microsecond time scale</article-title><source>Journal of Chemical Theory and Computation</source><volume>5</volume><fpage>1632</fpage><lpage>1639</lpage><pub-id pub-id-type="doi">10.1021/ct9000685</pub-id><pub-id pub-id-type="pmid">26609855</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Henzler-Wildman</surname><given-names>K</given-names></name><name><surname>Kern</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Dynamic personalities of proteins</article-title><source>Nature</source><volume>450</volume><fpage>964</fpage><lpage>972</lpage><pub-id pub-id-type="doi">10.1038/nature06522</pub-id><pub-id pub-id-type="pmid">18075575</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Høie</surname><given-names>MH</given-names></name><name><surname>Cagiada</surname><given-names>M</given-names></name><name><surname>Beck Frederiksen</surname><given-names>AH</given-names></name><name><surname>Stein</surname><given-names>A</given-names></name><name><surname>Lindorff-Larsen</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Predicting and interpreting large-scale mutagenesis data using analyses of protein stability and conservation</article-title><source>Cell Reports</source><volume>38</volume><elocation-id>110207</elocation-id><pub-id pub-id-type="doi">10.1016/j.celrep.2021.110207</pub-id><pub-id pub-id-type="pmid">35021073</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hopf</surname><given-names>TA</given-names></name><name><surname>Ingraham</surname><given-names>JB</given-names></name><name><surname>Poelwijk</surname><given-names>FJ</given-names></name><name><surname>Schärfe</surname><given-names>CPI</given-names></name><name><surname>Springer</surname><given-names>M</given-names></name><name><surname>Sander</surname><given-names>C</given-names></name><name><surname>Marks</surname><given-names>DS</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Mutation effects predicted from sequence co-variation</article-title><source>Nature Biotechnology</source><volume>35</volume><fpage>128</fpage><lpage>135</lpage><pub-id pub-id-type="doi">10.1038/nbt.3769</pub-id><pub-id pub-id-type="pmid">28092658</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Humphrey</surname><given-names>W</given-names></name><name><surname>Dalke</surname><given-names>A</given-names></name><name><surname>Schulten</surname><given-names>K</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>VMD: visual molecular dynamics</article-title><source>Journal of Molecular Graphics</source><volume>14</volume><fpage>33</fpage><lpage>38</lpage><pub-id pub-id-type="doi">10.1016/0263-7855(96)00018-5</pub-id><pub-id pub-id-type="pmid">8744570</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jacoby</surname><given-names>GA</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>AmpC beta-lactamases</article-title><source>Clinical Microbiology Reviews</source><volume>22</volume><fpage>161</fpage><lpage>182</lpage><pub-id pub-id-type="doi">10.1128/CMR.00036-08</pub-id><pub-id pub-id-type="pmid">19136439</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>James</surname><given-names>LC</given-names></name><name><surname>Tawfik</surname><given-names>DS</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Conformational diversity and protein evolution--a 60-year-old hypothesis revisited</article-title><source>Trends in Biochemical Sciences</source><volume>28</volume><fpage>361</fpage><lpage>368</lpage><pub-id pub-id-type="doi">10.1016/S0968-0004(03)00135-X</pub-id><pub-id pub-id-type="pmid">12878003</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jumper</surname><given-names>J</given-names></name><name><surname>Evans</surname><given-names>R</given-names></name><name><surname>Pritzel</surname><given-names>A</given-names></name><name><surname>Green</surname><given-names>T</given-names></name><name><surname>Figurnov</surname><given-names>M</given-names></name><name><surname>Ronneberger</surname><given-names>O</given-names></name><name><surname>Tunyasuvunakool</surname><given-names>K</given-names></name><name><surname>Bates</surname><given-names>R</given-names></name><name><surname>Žídek</surname><given-names>A</given-names></name><name><surname>Potapenko</surname><given-names>A</given-names></name><name><surname>Bridgland</surname><given-names>A</given-names></name><name><surname>Meyer</surname><given-names>C</given-names></name><name><surname>Kohl</surname><given-names>SAA</given-names></name><name><surname>Ballard</surname><given-names>AJ</given-names></name><name><surname>Cowie</surname><given-names>A</given-names></name><name><surname>Romera-Paredes</surname><given-names>B</given-names></name><name><surname>Nikolov</surname><given-names>S</given-names></name><name><surname>Jain</surname><given-names>R</given-names></name><name><surname>Adler</surname><given-names>J</given-names></name><name><surname>Back</surname><given-names>T</given-names></name><name><surname>Petersen</surname><given-names>S</given-names></name><name><surname>Reiman</surname><given-names>D</given-names></name><name><surname>Clancy</surname><given-names>E</given-names></name><name><surname>Zielinski</surname><given-names>M</given-names></name><name><surname>Steinegger</surname><given-names>M</given-names></name><name><surname>Pacholska</surname><given-names>M</given-names></name><name><surname>Berghammer</surname><given-names>T</given-names></name><name><surname>Bodenstein</surname><given-names>S</given-names></name><name><surname>Silver</surname><given-names>D</given-names></name><name><surname>Vinyals</surname><given-names>O</given-names></name><name><surname>Senior</surname><given-names>AW</given-names></name><name><surname>Kavukcuoglu</surname><given-names>K</given-names></name><name><surname>Kohli</surname><given-names>P</given-names></name><name><surname>Hassabis</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Highly accurate protein structure prediction with AlphaFold</article-title><source>Nature</source><volume>596</volume><fpage>583</fpage><lpage>589</lpage><pub-id pub-id-type="doi">10.1038/s41586-021-03819-2</pub-id><pub-id pub-id-type="pmid">34265844</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuzin</surname><given-names>AP</given-names></name><name><surname>Nukaga</surname><given-names>M</given-names></name><name><surname>Nukaga</surname><given-names>Y</given-names></name><name><surname>Hujer</surname><given-names>AM</given-names></name><name><surname>Bonomo</surname><given-names>RA</given-names></name><name><surname>Knox</surname><given-names>JR</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Structure of the SHV-1 beta-lactamase</article-title><source>Biochemistry</source><volume>38</volume><fpage>5720</fpage><lpage>5727</lpage><pub-id pub-id-type="doi">10.1021/bi990136d</pub-id><pub-id pub-id-type="pmid">10231522</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lange</surname><given-names>OF</given-names></name><name><surname>Grubmüller</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Generalized correlation for biomolecular dynamics</article-title><source>Proteins</source><volume>62</volume><fpage>1053</fpage><lpage>1061</lpage><pub-id pub-id-type="doi">10.1002/prot.20784</pub-id><pub-id pub-id-type="pmid">16355416</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liakopoulos</surname><given-names>A</given-names></name><name><surname>Mevius</surname><given-names>D</given-names></name><name><surname>Ceccarelli</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>A review of SHV extended-spectrum β-Lactamases: neglected yet ubiquitous</article-title><source>Frontiers in Microbiology</source><volume>7</volume><elocation-id>1374</elocation-id><pub-id pub-id-type="doi">10.3389/fmicb.2016.01374</pub-id><pub-id pub-id-type="pmid">27656166</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>Z</given-names></name><name><surname>Akin</surname><given-names>H</given-names></name><name><surname>Rao</surname><given-names>R</given-names></name><name><surname>Hie</surname><given-names>B</given-names></name><name><surname>Zhu</surname><given-names>Z</given-names></name><name><surname>Lu</surname><given-names>W</given-names></name><name><surname>Smetanin</surname><given-names>N</given-names></name><name><surname>Verkuil</surname><given-names>R</given-names></name><name><surname>Kabeli</surname><given-names>O</given-names></name><name><surname>Shmueli</surname><given-names>Y</given-names></name><name><surname>Dos Santos Costa</surname><given-names>A</given-names></name><name><surname>Fazel-Zarandi</surname><given-names>M</given-names></name><name><surname>Sercu</surname><given-names>T</given-names></name><name><surname>Candido</surname><given-names>S</given-names></name><name><surname>Rives</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Evolutionary-scale prediction of atomic-level protein structure with a language model</article-title><source>Science</source><volume>379</volume><fpage>1123</fpage><lpage>1130</lpage><pub-id pub-id-type="doi">10.1126/science.ade2574</pub-id><pub-id pub-id-type="pmid">36927031</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Bahar</surname><given-names>I</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Sequence evolution correlates with structural dynamics</article-title><source>Molecular Biology and Evolution</source><volume>29</volume><fpage>2253</fpage><lpage>2263</lpage><pub-id pub-id-type="doi">10.1093/molbev/mss097</pub-id><pub-id pub-id-type="pmid">22427707</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>S</given-names></name><name><surname>Hu</surname><given-names>L</given-names></name><name><surname>Lin</surname><given-names>H</given-names></name><name><surname>Judge</surname><given-names>A</given-names></name><name><surname>Rivera</surname><given-names>P</given-names></name><name><surname>Palaniappan</surname><given-names>M</given-names></name><name><surname>Sankaran</surname><given-names>B</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Prasad</surname><given-names>BVV</given-names></name><name><surname>Palzkill</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>An active site loop toggles between conformations to control antibiotic hydrolysis and inhibition potency for CTX-M β-lactamase drug-resistance enzymes</article-title><source>Nature Communications</source><volume>13</volume><elocation-id>6726</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-022-34564-3</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maier</surname><given-names>JA</given-names></name><name><surname>Martinez</surname><given-names>C</given-names></name><name><surname>Kasavajhala</surname><given-names>K</given-names></name><name><surname>Wickstrom</surname><given-names>L</given-names></name><name><surname>Hauser</surname><given-names>KE</given-names></name><name><surname>Simmerling</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>ff14SB: improving the accuracy of protein side chain and backbone parameters from ff99SB</article-title><source>Journal of Chemical Theory and Computation</source><volume>11</volume><fpage>3696</fpage><lpage>3713</lpage><pub-id pub-id-type="doi">10.1021/acs.jctc.5b00255</pub-id><pub-id pub-id-type="pmid">26574453</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marks</surname><given-names>DS</given-names></name><name><surname>Hopf</surname><given-names>TA</given-names></name><name><surname>Sander</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Protein structure prediction from sequence variation</article-title><source>Nature Biotechnology</source><volume>30</volume><fpage>1072</fpage><lpage>1080</lpage><pub-id pub-id-type="doi">10.1038/nbt.2419</pub-id><pub-id pub-id-type="pmid">23138306</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martínez-Rosell</surname><given-names>G</given-names></name><name><surname>Giorgino</surname><given-names>T</given-names></name><name><surname>De Fabritiis</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>PlayMolecule proteinprepare: a web application for protein preparation for molecular dynamics simulations</article-title><source>Journal of Chemical Information and Modeling</source><volume>57</volume><fpage>1511</fpage><lpage>1516</lpage><pub-id pub-id-type="doi">10.1021/acs.jcim.7b00190</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matagne</surname><given-names>A</given-names></name><name><surname>Lamotte-Brasseur</surname><given-names>J</given-names></name><name><surname>Frère</surname><given-names>JM</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Catalytic properties of class A beta-lactamases: efficiency and diversity</article-title><source>The Biochemical Journal</source><volume>330 (Pt 2)</volume><fpage>581</fpage><lpage>598</lpage><pub-id pub-id-type="doi">10.1042/bj3300581</pub-id><pub-id pub-id-type="pmid">9480862</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matreyek</surname><given-names>KA</given-names></name><name><surname>Starita</surname><given-names>LM</given-names></name><name><surname>Stephany</surname><given-names>JJ</given-names></name><name><surname>Martin</surname><given-names>B</given-names></name><name><surname>Chiasson</surname><given-names>MA</given-names></name><name><surname>Gray</surname><given-names>VE</given-names></name><name><surname>Kircher</surname><given-names>M</given-names></name><name><surname>Khechaduri</surname><given-names>A</given-names></name><name><surname>Dines</surname><given-names>JN</given-names></name><name><surname>Hause</surname><given-names>RJ</given-names></name><name><surname>Bhatia</surname><given-names>S</given-names></name><name><surname>Evans</surname><given-names>WE</given-names></name><name><surname>Relling</surname><given-names>MV</given-names></name><name><surname>Yang</surname><given-names>W</given-names></name><name><surname>Shendure</surname><given-names>J</given-names></name><name><surname>Fowler</surname><given-names>DM</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Multiplex assessment of protein variant abundance by massively parallel sequencing</article-title><source>Nature Genetics</source><volume>50</volume><fpage>874</fpage><lpage>882</lpage><pub-id pub-id-type="doi">10.1038/s41588-018-0122-z</pub-id><pub-id pub-id-type="pmid">29785012</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Medeiros</surname><given-names>AA</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>β-Lactamases: quality and resistance</article-title><source>Clinical Microbiology and Infection</source><volume>3</volume><fpage>4S2</fpage><lpage>4S9</lpage><pub-id pub-id-type="doi">10.1016/S1198-743X(14)65030-8</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Michaud-Agrawal</surname><given-names>N</given-names></name><name><surname>Denning</surname><given-names>EJ</given-names></name><name><surname>Woolf</surname><given-names>TB</given-names></name><name><surname>Beckstein</surname><given-names>O</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>MDAnalysis: a toolkit for the analysis of molecular dynamics simulations</article-title><source>Journal of Computational Chemistry</source><volume>32</volume><fpage>2319</fpage><lpage>2327</lpage><pub-id pub-id-type="doi">10.1002/jcc.21787</pub-id><pub-id pub-id-type="pmid">21500218</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mirdita</surname><given-names>M</given-names></name><name><surname>von den Driesch</surname><given-names>L</given-names></name><name><surname>Galiez</surname><given-names>C</given-names></name><name><surname>Martin</surname><given-names>MJ</given-names></name><name><surname>Söding</surname><given-names>J</given-names></name><name><surname>Steinegger</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Uniclust databases of clustered and deeply annotated protein sequences and alignments</article-title><source>Nucleic Acids Research</source><volume>45</volume><fpage>D170</fpage><lpage>D176</lpage><pub-id pub-id-type="doi">10.1093/nar/gkw1081</pub-id><pub-id pub-id-type="pmid">27899574</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Negre</surname><given-names>CFA</given-names></name><name><surname>Morzan</surname><given-names>UN</given-names></name><name><surname>Hendrickson</surname><given-names>HP</given-names></name><name><surname>Pal</surname><given-names>R</given-names></name><name><surname>Lisi</surname><given-names>GP</given-names></name><name><surname>Loria</surname><given-names>JP</given-names></name><name><surname>Rivalta</surname><given-names>I</given-names></name><name><surname>Ho</surname><given-names>J</given-names></name><name><surname>Batista</surname><given-names>VS</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Eigenvector centrality for characterization of protein allosteric pathways</article-title><source>PNAS</source><volume>115</volume><fpage>E12201</fpage><lpage>E12208</lpage><pub-id pub-id-type="doi">10.1073/pnas.1810452115</pub-id><pub-id pub-id-type="pmid">30530700</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neubauer</surname><given-names>S</given-names></name><name><surname>Madzgalla</surname><given-names>S</given-names></name><name><surname>Marquet</surname><given-names>M</given-names></name><name><surname>Klabunde</surname><given-names>A</given-names></name><name><surname>Büttner</surname><given-names>B</given-names></name><name><surname>Göhring</surname><given-names>A</given-names></name><name><surname>Brandt</surname><given-names>C</given-names></name><name><surname>Feller</surname><given-names>K-H</given-names></name><name><surname>Pletz</surname><given-names>MW</given-names></name><name><surname>Makarewicz</surname><given-names>O</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>A genotype-phenotype correlation study of shv β-lactamases offers new insight into SHV resistance profiles</article-title><source>Antimicrobial Agents and Chemotherapy</source><volume>64</volume><elocation-id>e02293-19</elocation-id><pub-id pub-id-type="doi">10.1128/AAC.02293-19</pub-id><pub-id pub-id-type="pmid">32284385</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nevin Gerek</surname><given-names>Z</given-names></name><name><surname>Kumar</surname><given-names>S</given-names></name><name><surname>Banu Ozkan</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Structural dynamics flexibility informs function and evolution at a proteome scale</article-title><source>Evolutionary Applications</source><volume>6</volume><fpage>423</fpage><lpage>433</lpage><pub-id pub-id-type="doi">10.1111/eva.12052</pub-id><pub-id pub-id-type="pmid">23745135</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Newman</surname><given-names>MEJ</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Detecting community structure in networks</article-title><source>The European Physical Journal B - Condensed Matter</source><volume>38</volume><fpage>321</fpage><lpage>330</lpage><pub-id pub-id-type="doi">10.1140/epjb/e2004-00124-y</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Newman</surname><given-names>MEJ</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Finding community structure in networks using the eigenvectors of matrices</article-title><source>Physical Review E</source><volume>74</volume><elocation-id>036104</elocation-id><pub-id pub-id-type="doi">10.1103/PhysRevE.74.036104</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nicolas</surname><given-names>MH</given-names></name><name><surname>Jarlier</surname><given-names>V</given-names></name><name><surname>Honore</surname><given-names>N</given-names></name><name><surname>Philippon</surname><given-names>A</given-names></name><name><surname>Cole</surname><given-names>ST</given-names></name></person-group><year iso-8601-date="1989">1989</year><article-title>Molecular characterization of the gene encoding SHV-3 beta-lactamase responsible for transferable cefotaxime resistance in clinical isolates of Klebsiella pneumoniae</article-title><source>Antimicrobial Agents and Chemotherapy</source><volume>33</volume><fpage>2096</fpage><lpage>2100</lpage><pub-id pub-id-type="doi">10.1128/AAC.33.12.2096</pub-id><pub-id pub-id-type="pmid">2694951</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olehnovics</surname><given-names>E</given-names></name><name><surname>Yin</surname><given-names>J</given-names></name><name><surname>Pérez</surname><given-names>A</given-names></name><name><surname>De Fabritiis</surname><given-names>G</given-names></name><name><surname>Bonomo</surname><given-names>RA</given-names></name><name><surname>Bhowmik</surname><given-names>D</given-names></name><name><surname>Haider</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>The role of hydrophobic nodes in the dynamics of class a β-lactamases</article-title><source>Frontiers in Microbiology</source><volume>12</volume><elocation-id>720991</elocation-id><pub-id pub-id-type="doi">10.3389/fmicb.2021.720991</pub-id><pub-id pub-id-type="pmid">34621251</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Osuna</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>The challenge of predicting distal active site mutations in computational enzyme design</article-title><source>WIREs Computational Molecular Science</source><volume>11</volume><elocation-id>1502</elocation-id><pub-id pub-id-type="doi">10.1002/wcms.1502</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pagan-Rodriguez</surname><given-names>D</given-names></name><name><surname>Zhou</surname><given-names>X</given-names></name><name><surname>Simmons</surname><given-names>R</given-names></name><name><surname>Bethel</surname><given-names>CR</given-names></name><name><surname>Hujer</surname><given-names>AM</given-names></name><name><surname>Helfand</surname><given-names>MS</given-names></name><name><surname>Jin</surname><given-names>Z</given-names></name><name><surname>Guo</surname><given-names>B</given-names></name><name><surname>Anderson</surname><given-names>VE</given-names></name><name><surname>Ng</surname><given-names>LM</given-names></name><name><surname>Bonomo</surname><given-names>RA</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Tazobactam inactivation of SHV-1 and the inhibitor-resistant Ser130 --&gt;Gly SHV-1 beta-lactamase: insights into the mechanism of inhibition</article-title><source>The Journal of Biological Chemistry</source><volume>279</volume><fpage>19494</fpage><lpage>19501</lpage><pub-id pub-id-type="doi">10.1074/jbc.M311669200</pub-id><pub-id pub-id-type="pmid">14757767</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palzkill</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Structural and mechanistic basis for extended-spectrum drug-resistance mutations in altering the specificity of tem, ctx-m, and kpc β-lactamases</article-title><source>Frontiers in Molecular Biosciences</source><volume>5</volume><elocation-id>16</elocation-id><pub-id pub-id-type="doi">10.3389/fmolb.2018.00016</pub-id><pub-id pub-id-type="pmid">29527530</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Pandini</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2024">2024</year><data-title>DyNoPy (dynamics based network comparisons in python)</data-title><version designator="swh:1:rev:2291e30a69c7e8ac743a62ad7a9c79a0bdcd0bc9">swh:1:rev:2291e30a69c7e8ac743a62ad7a9c79a0bdcd0bc9</version><source>Software Heritage</source><ext-link ext-link-type="uri" xlink:href="https://archive.softwareheritage.org/swh:1:dir:2a4390c9a521fd4a7e2260a5f738cdcd2570c6ea;origin=https://github.com/alepandini/DyNoPy;visit=swh:1:snp:604ebe1ee6675b0f9cc531b176ebc232693cad98;anchor=swh:1:rev:2291e30a69c7e8ac743a62ad7a9c79a0bdcd0bc9">https://archive.softwareheritage.org/swh:1:dir:2a4390c9a521fd4a7e2260a5f738cdcd2570c6ea;origin=https://github.com/alepandini/DyNoPy;visit=swh:1:snp:604ebe1ee6675b0f9cc531b176ebc232693cad98;anchor=swh:1:rev:2291e30a69c7e8ac743a62ad7a9c79a0bdcd0bc9</ext-link></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parente</surname><given-names>DJ</given-names></name><name><surname>Ray</surname><given-names>JCJ</given-names></name><name><surname>Swint-Kruse</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Amino acid positions subject to multiple coevolutionary constraints can be robustly identified by their eigenvector network centrality scores</article-title><source>Proteins</source><volume>83</volume><fpage>2293</fpage><lpage>2306</lpage><pub-id pub-id-type="doi">10.1002/prot.24948</pub-id><pub-id pub-id-type="pmid">26503808</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parwana</surname><given-names>D</given-names></name><name><surname>Gu</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Bethel</surname><given-names>CR</given-names></name><name><surname>Marshall</surname><given-names>E</given-names></name><name><surname>Hujer</surname><given-names>AM</given-names></name><name><surname>Bonomo</surname><given-names>RA</given-names></name><name><surname>Haider</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2024">2024</year><article-title>The structural role of N170 in substrate-assisted deacylation in KPC-2 β-Lactamase</article-title><source>Angewandte Chemie</source><volume>63</volume><elocation-id>e202317315</elocation-id><pub-id pub-id-type="doi">10.1002/anie.202317315</pub-id><pub-id pub-id-type="pmid">38227422</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Philippon</surname><given-names>A</given-names></name><name><surname>Arlet</surname><given-names>G</given-names></name><name><surname>Labia</surname><given-names>R</given-names></name><name><surname>Iorga</surname><given-names>BI</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Class c β-lactamases: molecular characteristics</article-title><source>Clinical Microbiology Reviews</source><volume>35</volume><elocation-id>e0015021</elocation-id><pub-id pub-id-type="doi">10.1128/cmr.00150-21</pub-id><pub-id pub-id-type="pmid">35435729</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poelwijk</surname><given-names>FJ</given-names></name><name><surname>Krishna</surname><given-names>V</given-names></name><name><surname>Ranganathan</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The context-dependence of mutations: a linkage of formalisms</article-title><source>PLOS Computational Biology</source><volume>12</volume><elocation-id>e1004771</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pcbi.1004771</pub-id><pub-id pub-id-type="pmid">27337695</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poirel</surname><given-names>L</given-names></name><name><surname>Héritier</surname><given-names>C</given-names></name><name><surname>Podglajen</surname><given-names>I</given-names></name><name><surname>Sougakoff</surname><given-names>W</given-names></name><name><surname>Gutmann</surname><given-names>L</given-names></name><name><surname>Nordmann</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Emergence in <italic>Klebsiella pneumoniae</italic> of a chromosome-encoded shv β-lactamase that compromises the efficacy of imipenem</article-title><source>Antimicrobial Agents and Chemotherapy</source><volume>47</volume><fpage>755</fpage><lpage>758</lpage><pub-id pub-id-type="doi">10.1128/AAC.47.2.755-758.2003</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poirel</surname><given-names>L</given-names></name><name><surname>Docquier</surname><given-names>J-D</given-names></name><name><surname>De Luca</surname><given-names>F</given-names></name><name><surname>Verlinde</surname><given-names>A</given-names></name><name><surname>Ide</surname><given-names>L</given-names></name><name><surname>Rossolini</surname><given-names>GM</given-names></name><name><surname>Nordmann</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>BEL-2, an extended-spectrum β-lactamase with increased activity toward expanded-spectrum cephalosporins in <italic>Pseudomonas aeruginosa</italic></article-title><source>Antimicrobial Agents and Chemotherapy</source><volume>54</volume><fpage>533</fpage><lpage>535</lpage><pub-id pub-id-type="doi">10.1128/AAC.00859-09</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ponzoni</surname><given-names>L</given-names></name><name><surname>Polles</surname><given-names>G</given-names></name><name><surname>Carnevale</surname><given-names>V</given-names></name><name><surname>Micheletti</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>SPECTRUS: a dimensionality reduction approach for identifying dynamical domains in protein complexes from limited structural datasets</article-title><source>Structure</source><volume>23</volume><fpage>1516</fpage><lpage>1525</lpage><pub-id pub-id-type="doi">10.1016/j.str.2015.05.022</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poole</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Resistance to beta-lactam antibiotics</article-title><source>Cellular and Molecular Life Sciences</source><volume>61</volume><fpage>2200</fpage><lpage>2223</lpage><pub-id pub-id-type="doi">10.1007/s00018-004-4060-9</pub-id><pub-id pub-id-type="pmid">15338052</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pozzi</surname><given-names>C</given-names></name><name><surname>De Luca</surname><given-names>F</given-names></name><name><surname>Benvenuti</surname><given-names>M</given-names></name><name><surname>Poirel</surname><given-names>L</given-names></name><name><surname>Nordmann</surname><given-names>P</given-names></name><name><surname>Rossolini</surname><given-names>GM</given-names></name><name><surname>Mangani</surname><given-names>S</given-names></name><name><surname>Docquier</surname><given-names>J-D</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Crystal structure of the <italic>Pseudomonas aeruginosa</italic> bel-1 extended-spectrum β-lactamase and its complexes with moxalactam and imipenem</article-title><source>Antimicrobial Agents and Chemotherapy</source><volume>60</volume><fpage>7189</fpage><lpage>7199</lpage><pub-id pub-id-type="doi">10.1128/AAC.00936-16</pub-id><pub-id pub-id-type="pmid">27671060</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Radivojac</surname><given-names>P</given-names></name><name><surname>Clark</surname><given-names>WT</given-names></name><name><surname>Oron</surname><given-names>TR</given-names></name><name><surname>Schnoes</surname><given-names>AM</given-names></name><name><surname>Wittkop</surname><given-names>T</given-names></name><name><surname>Sokolov</surname><given-names>A</given-names></name><name><surname>Graim</surname><given-names>K</given-names></name><name><surname>Funk</surname><given-names>C</given-names></name><name><surname>Verspoor</surname><given-names>K</given-names></name><name><surname>Ben-Hur</surname><given-names>A</given-names></name><name><surname>Pandey</surname><given-names>G</given-names></name><name><surname>Yunes</surname><given-names>JM</given-names></name><name><surname>Talwalkar</surname><given-names>AS</given-names></name><name><surname>Repo</surname><given-names>S</given-names></name><name><surname>Souza</surname><given-names>ML</given-names></name><name><surname>Piovesan</surname><given-names>D</given-names></name><name><surname>Casadio</surname><given-names>R</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Cheng</surname><given-names>J</given-names></name><name><surname>Fang</surname><given-names>H</given-names></name><name><surname>Gough</surname><given-names>J</given-names></name><name><surname>Koskinen</surname><given-names>P</given-names></name><name><surname>Törönen</surname><given-names>P</given-names></name><name><surname>Nokso-Koivisto</surname><given-names>J</given-names></name><name><surname>Holm</surname><given-names>L</given-names></name><name><surname>Cozzetto</surname><given-names>D</given-names></name><name><surname>Buchan</surname><given-names>DWA</given-names></name><name><surname>Bryson</surname><given-names>K</given-names></name><name><surname>Jones</surname><given-names>DT</given-names></name><name><surname>Limaye</surname><given-names>B</given-names></name><name><surname>Inamdar</surname><given-names>H</given-names></name><name><surname>Datta</surname><given-names>A</given-names></name><name><surname>Manjari</surname><given-names>SK</given-names></name><name><surname>Joshi</surname><given-names>R</given-names></name><name><surname>Chitale</surname><given-names>M</given-names></name><name><surname>Kihara</surname><given-names>D</given-names></name><name><surname>Lisewski</surname><given-names>AM</given-names></name><name><surname>Erdin</surname><given-names>S</given-names></name><name><surname>Venner</surname><given-names>E</given-names></name><name><surname>Lichtarge</surname><given-names>O</given-names></name><name><surname>Rentzsch</surname><given-names>R</given-names></name><name><surname>Yang</surname><given-names>H</given-names></name><name><surname>Romero</surname><given-names>AE</given-names></name><name><surname>Bhat</surname><given-names>P</given-names></name><name><surname>Paccanaro</surname><given-names>A</given-names></name><name><surname>Hamp</surname><given-names>T</given-names></name><name><surname>Kaßner</surname><given-names>R</given-names></name><name><surname>Seemayer</surname><given-names>S</given-names></name><name><surname>Vicedo</surname><given-names>E</given-names></name><name><surname>Schaefer</surname><given-names>C</given-names></name><name><surname>Achten</surname><given-names>D</given-names></name><name><surname>Auer</surname><given-names>F</given-names></name><name><surname>Boehm</surname><given-names>A</given-names></name><name><surname>Braun</surname><given-names>T</given-names></name><name><surname>Hecht</surname><given-names>M</given-names></name><name><surname>Heron</surname><given-names>M</given-names></name><name><surname>Hönigschmid</surname><given-names>P</given-names></name><name><surname>Hopf</surname><given-names>TA</given-names></name><name><surname>Kaufmann</surname><given-names>S</given-names></name><name><surname>Kiening</surname><given-names>M</given-names></name><name><surname>Krompass</surname><given-names>D</given-names></name><name><surname>Landerer</surname><given-names>C</given-names></name><name><surname>Mahlich</surname><given-names>Y</given-names></name><name><surname>Roos</surname><given-names>M</given-names></name><name><surname>Björne</surname><given-names>J</given-names></name><name><surname>Salakoski</surname><given-names>T</given-names></name><name><surname>Wong</surname><given-names>A</given-names></name><name><surname>Shatkay</surname><given-names>H</given-names></name><name><surname>Gatzmann</surname><given-names>F</given-names></name><name><surname>Sommer</surname><given-names>I</given-names></name><name><surname>Wass</surname><given-names>MN</given-names></name><name><surname>Sternberg</surname><given-names>MJE</given-names></name><name><surname>Škunca</surname><given-names>N</given-names></name><name><surname>Supek</surname><given-names>F</given-names></name><name><surname>Bošnjak</surname><given-names>M</given-names></name><name><surname>Panov</surname><given-names>P</given-names></name><name><surname>Džeroski</surname><given-names>S</given-names></name><name><surname>Šmuc</surname><given-names>T</given-names></name><name><surname>Kourmpetis</surname><given-names>YAI</given-names></name><name><surname>van Dijk</surname><given-names>ADJ</given-names></name><name><surname>ter Braak</surname><given-names>CJF</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Gong</surname><given-names>Q</given-names></name><name><surname>Dong</surname><given-names>X</given-names></name><name><surname>Tian</surname><given-names>W</given-names></name><name><surname>Falda</surname><given-names>M</given-names></name><name><surname>Fontana</surname><given-names>P</given-names></name><name><surname>Lavezzo</surname><given-names>E</given-names></name><name><surname>Di Camillo</surname><given-names>B</given-names></name><name><surname>Toppo</surname><given-names>S</given-names></name><name><surname>Lan</surname><given-names>L</given-names></name><name><surname>Djuric</surname><given-names>N</given-names></name><name><surname>Guo</surname><given-names>Y</given-names></name><name><surname>Vucetic</surname><given-names>S</given-names></name><name><surname>Bairoch</surname><given-names>A</given-names></name><name><surname>Linial</surname><given-names>M</given-names></name><name><surname>Babbitt</surname><given-names>PC</given-names></name><name><surname>Brenner</surname><given-names>SE</given-names></name><name><surname>Orengo</surname><given-names>C</given-names></name><name><surname>Rost</surname><given-names>B</given-names></name><name><surname>Mooney</surname><given-names>SD</given-names></name><name><surname>Friedberg</surname><given-names>I</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>A large-scale evaluation of computational protein function prediction</article-title><source>Nature Methods</source><volume>10</volume><fpage>221</fpage><lpage>227</lpage><pub-id pub-id-type="doi">10.1038/nmeth.2340</pub-id><pub-id pub-id-type="pmid">23353650</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Remmert</surname><given-names>M</given-names></name><name><surname>Biegert</surname><given-names>A</given-names></name><name><surname>Hauser</surname><given-names>A</given-names></name><name><surname>Söding</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>HHblits: lightning-fast iterative protein sequence searching by HMM-HMM alignment</article-title><source>Nature Methods</source><volume>9</volume><fpage>173</fpage><lpage>175</lpage><pub-id pub-id-type="doi">10.1038/nmeth.1818</pub-id><pub-id pub-id-type="pmid">22198341</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodrigues</surname><given-names>CHM</given-names></name><name><surname>Pires</surname><given-names>DEV</given-names></name><name><surname>Ascher</surname><given-names>DB</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>DynaMut2: Assessing changes in stability and flexibility upon single and multiple point missense mutations</article-title><source>Protein Science</source><volume>30</volume><fpage>60</fpage><lpage>69</lpage><pub-id pub-id-type="doi">10.1002/pro.3942</pub-id><pub-id pub-id-type="pmid">32881105</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Russ</surname><given-names>WP</given-names></name><name><surname>Figliuzzi</surname><given-names>M</given-names></name><name><surname>Stocker</surname><given-names>C</given-names></name><name><surname>Barrat-Charlaix</surname><given-names>P</given-names></name><name><surname>Socolich</surname><given-names>M</given-names></name><name><surname>Kast</surname><given-names>P</given-names></name><name><surname>Hilvert</surname><given-names>D</given-names></name><name><surname>Monasson</surname><given-names>R</given-names></name><name><surname>Cocco</surname><given-names>S</given-names></name><name><surname>Weigt</surname><given-names>M</given-names></name><name><surname>Ranganathan</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>An evolution-based model for designing chorismate mutase enzymes</article-title><source>Science</source><volume>369</volume><fpage>440</fpage><lpage>445</lpage><pub-id pub-id-type="doi">10.1126/science.aba3304</pub-id><pub-id pub-id-type="pmid">32703877</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scherer</surname><given-names>MK</given-names></name><name><surname>Trendelkamp-Schroer</surname><given-names>B</given-names></name><name><surname>Paul</surname><given-names>F</given-names></name><name><surname>Pérez-Hernández</surname><given-names>G</given-names></name><name><surname>Hoffmann</surname><given-names>M</given-names></name><name><surname>Plattner</surname><given-names>N</given-names></name><name><surname>Wehmeyer</surname><given-names>C</given-names></name><name><surname>Prinz</surname><given-names>J-H</given-names></name><name><surname>Noé</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>PyEMMA 2: a software package for estimation, validation, and analysis of markov models</article-title><source>Journal of Chemical Theory and Computation</source><volume>11</volume><fpage>5525</fpage><lpage>5542</lpage><pub-id pub-id-type="doi">10.1021/acs.jctc.5b00743</pub-id><pub-id pub-id-type="pmid">26574340</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmidtke</surname><given-names>P</given-names></name><name><surname>Bidon-Chanal</surname><given-names>A</given-names></name><name><surname>Luque</surname><given-names>FJ</given-names></name><name><surname>Barril</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>MDpocket: open-source cavity detection and characterization on molecular dynamics trajectories</article-title><source>Bioinformatics</source><volume>27</volume><fpage>3276</fpage><lpage>3285</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btr550</pub-id><pub-id pub-id-type="pmid">21967761</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seemayer</surname><given-names>S</given-names></name><name><surname>Gruber</surname><given-names>M</given-names></name><name><surname>Söding</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>CCMpred--fast and precise prediction of protein residue-residue contacts from correlated mutations</article-title><source>Bioinformatics</source><volume>30</volume><fpage>3128</fpage><lpage>3130</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btu500</pub-id><pub-id pub-id-type="pmid">25064567</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soskine</surname><given-names>M</given-names></name><name><surname>Tawfik</surname><given-names>DS</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Mutational effects and the evolution of new protein functions</article-title><source>Nature Reviews. Genetics</source><volume>11</volume><fpage>572</fpage><lpage>582</lpage><pub-id pub-id-type="doi">10.1038/nrg2808</pub-id><pub-id pub-id-type="pmid">20634811</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stenson</surname><given-names>PD</given-names></name><name><surname>Mort</surname><given-names>M</given-names></name><name><surname>Ball</surname><given-names>EV</given-names></name><name><surname>Evans</surname><given-names>K</given-names></name><name><surname>Hayden</surname><given-names>M</given-names></name><name><surname>Heywood</surname><given-names>S</given-names></name><name><surname>Hussain</surname><given-names>M</given-names></name><name><surname>Phillips</surname><given-names>AD</given-names></name><name><surname>Cooper</surname><given-names>DN</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>The Human Gene Mutation Database: towards a comprehensive repository of inherited mutation data for medical research, genetic diagnosis and next-generation sequencing studies</article-title><source>Human Genetics</source><volume>136</volume><fpage>665</fpage><lpage>677</lpage><pub-id pub-id-type="doi">10.1007/s00439-017-1779-6</pub-id><pub-id pub-id-type="pmid">28349240</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sutto</surname><given-names>L</given-names></name><name><surname>Marsili</surname><given-names>S</given-names></name><name><surname>Valencia</surname><given-names>A</given-names></name><name><surname>Gervasio</surname><given-names>FL</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>From residue coevolution to protein conformational ensembles and functional dynamics</article-title><source>PNAS</source><volume>112</volume><fpage>13567</fpage><lpage>13572</lpage><pub-id pub-id-type="doi">10.1073/pnas.1508584112</pub-id><pub-id pub-id-type="pmid">26487681</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Huang</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Molecular dynamics simulations and statistical coupling analysis reveal functional coevolution network of oncogenic mutations in the CDKN2A-CDK6 complex</article-title><source>FEBS Letters</source><volume>587</volume><fpage>136</fpage><lpage>141</lpage><pub-id pub-id-type="doi">10.1016/j.febslet.2012.11.001</pub-id><pub-id pub-id-type="pmid">23178718</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wodak</surname><given-names>SJ</given-names></name><name><surname>Paci</surname><given-names>E</given-names></name><name><surname>Dokholyan</surname><given-names>NV</given-names></name><name><surname>Berezovsky</surname><given-names>IN</given-names></name><name><surname>Horovitz</surname><given-names>A</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Hilser</surname><given-names>VJ</given-names></name><name><surname>Bahar</surname><given-names>I</given-names></name><name><surname>Karanicolas</surname><given-names>J</given-names></name><name><surname>Stock</surname><given-names>G</given-names></name><name><surname>Hamm</surname><given-names>P</given-names></name><name><surname>Stote</surname><given-names>RH</given-names></name><name><surname>Eberhardt</surname><given-names>J</given-names></name><name><surname>Chebaro</surname><given-names>Y</given-names></name><name><surname>Dejaegere</surname><given-names>A</given-names></name><name><surname>Cecchini</surname><given-names>M</given-names></name><name><surname>Changeux</surname><given-names>J-P</given-names></name><name><surname>Bolhuis</surname><given-names>PG</given-names></name><name><surname>Vreede</surname><given-names>J</given-names></name><name><surname>Faccioli</surname><given-names>P</given-names></name><name><surname>Orioli</surname><given-names>S</given-names></name><name><surname>Ravasio</surname><given-names>R</given-names></name><name><surname>Yan</surname><given-names>L</given-names></name><name><surname>Brito</surname><given-names>C</given-names></name><name><surname>Wyart</surname><given-names>M</given-names></name><name><surname>Gkeka</surname><given-names>P</given-names></name><name><surname>Rivalta</surname><given-names>I</given-names></name><name><surname>Palermo</surname><given-names>G</given-names></name><name><surname>McCammon</surname><given-names>JA</given-names></name><name><surname>Panecka-Hofman</surname><given-names>J</given-names></name><name><surname>Wade</surname><given-names>RC</given-names></name><name><surname>Di Pizio</surname><given-names>A</given-names></name><name><surname>Niv</surname><given-names>MY</given-names></name><name><surname>Nussinov</surname><given-names>R</given-names></name><name><surname>Tsai</surname><given-names>C-J</given-names></name><name><surname>Jang</surname><given-names>H</given-names></name><name><surname>Padhorny</surname><given-names>D</given-names></name><name><surname>Kozakov</surname><given-names>D</given-names></name><name><surname>McLeish</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Allostery in its many disguises: from theory to applications</article-title><source>Structure</source><volume>27</volume><fpage>566</fpage><lpage>578</lpage><pub-id pub-id-type="doi">10.1016/j.str.2019.01.003</pub-id><pub-id pub-id-type="pmid">30744993</pub-id></element-citation></ref><ref id="bib90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>Z</given-names></name><name><surname>Kan</surname><given-names>SBJ</given-names></name><name><surname>Lewis</surname><given-names>RD</given-names></name><name><surname>Wittmann</surname><given-names>BJ</given-names></name><name><surname>Arnold</surname><given-names>FH</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Machine learning-assisted directed protein evolution with combinatorial libraries</article-title><source>PNAS</source><volume>116</volume><fpage>8852</fpage><lpage>8858</lpage><pub-id pub-id-type="doi">10.1073/pnas.1901979116</pub-id><pub-id pub-id-type="pmid">30979809</pub-id></element-citation></ref><ref id="bib91"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yehorova</surname><given-names>D</given-names></name><name><surname>Crean</surname><given-names>RM</given-names></name><name><surname>Kasson</surname><given-names>PM</given-names></name><name><surname>Kamerlin</surname><given-names>SCL</given-names></name></person-group><year iso-8601-date="2024">2024</year><article-title>Key interaction networks: Identifying evolutionarily conserved non-covalent interaction networks across protein families</article-title><source>Protein Science</source><volume>33</volume><elocation-id>e4911</elocation-id><pub-id pub-id-type="doi">10.1002/pro.4911</pub-id><pub-id pub-id-type="pmid">38358258</pub-id></element-citation></ref></ref-list><app-group><app id="appendix-1"><title>Appendix 1</title><sec sec-type="appendix" id="s7"><title>Interaction energies (E)</title><p>The pairwise non-bonded interaction energies for the upper triangle of the N×N residue matrix are calculated using dyno_pwie.py, which is a wrapper to ccptraj from ambertools. The list of pairs is generated and depending on the number of available threads (n<sub>t</sub>), ‘<italic>n</italic>’ sets of pairs are created, and each pair set is assigned to an instance of ccptraj for calculation of pairwise interaction energies. As this is a RAM-dependent operation, based on the size of the MD trajectory, care must be taken to not spawn too many instances of ccptraj as it will slow down each instance of the ccptraj calculation. For each residue pair (<inline-formula><mml:math id="inf22"><mml:msub><mml:mrow><mml:mi mathvariant="normal">r</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">j</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>), a separate file with coulomb (<inline-formula><mml:math id="inf23"><mml:msub><mml:mrow><mml:mi>q</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>) and van der Waals (<inline-formula><mml:math id="inf24"><mml:msub><mml:mrow><mml:mi>w</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>) interaction energies, as two separate columns, are saved to a h5py compressed file and the total interaction energy (<inline-formula><mml:math id="inf25"><mml:msub><mml:mrow><mml:mi>ϵ</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>)</mml:mo></mml:math></inline-formula> for each time step can be calculated from this data using <xref ref-type="disp-formula" rid="equ6">Equation A1</xref>.<disp-formula id="equ6"><label>(A1)</label><mml:math id="m6"><mml:mrow><mml:msub><mml:mi>ϵ</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mi>q</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>w</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:math></disp-formula></p></sec><sec sec-type="appendix" id="s8"><title>Collective variables description</title><sec sec-type="appendix" id="s8-1"><title>Radius of gyration (Rg)</title><p>The radius of gyration (Rg) measures the compactness of the protein structure through the calculation of the root mean square distance of all atoms from the centre of mass. A lower Rg indicates a more compact structure, while a higher Rg suggests a more expanded or unfolded state. This CV was calculated using the MDAnalysis v2.7.0 (<xref ref-type="bibr" rid="bib34">Gowers et al., 2016</xref>; <xref ref-type="bibr" rid="bib56">Michaud-Agrawal et al., 2011</xref>), focusing on the whole protein for both enzymes.</p></sec><sec sec-type="appendix" id="s8-2"><title>The first principal component (PC1)</title><p>Principal component analysis identifies the major dynamical feature of a protein by reducing the dimensionality directly from molecular dynamics simulation data. PC1 represents the largest variance on the selected features across the simulation. Global PC1 was computed using PyEMMA v2.5.12 (<xref ref-type="bibr" rid="bib82">Scherer et al., 2015</xref>), focusing on backbone torsion angles and χ1 angles for all residues, capturing the global dominant structural changes.</p></sec><sec sec-type="appendix" id="s8-3"><title>The partial PC1 (PC1_partial)</title><p>PC1_partial was calculated using the same methodology as PC1 but only focusing on functionally significant residues and essential secondary structures. This approach prioritizes the dynamics within regions critical to the protein’s function, thereby providing a more targeted analysis of pertinent conformational changes. It is particularly well-suited for studying proteins that are predominantly rigid with localized flexible regions.</p></sec><sec sec-type="appendix" id="s8-4"><title>Time-lagged independent component 1 (TC1)</title><p>Time-lagged independent component analysisidentifies slow, independent processes within the protein dynamics. TC1 captures the slowest conformational changes in the protein over time. It was computed globally using backbone torsion angles and χ1 angles for all residues, with PyEMMA v2.5.12 (<xref ref-type="bibr" rid="bib82">Scherer et al., 2015</xref>).</p></sec><sec sec-type="appendix" id="s8-5"><title>Partial time-lagged independent component 1 (TC1_partial)</title><p>Similarly, TC1_partial was calculated, but focused on specific, functionally important regions. By analysing these key residues and structures, TC1_partial represents the slow conformational changes crucial within essential regions, which are highly corresponding with protein functions.</p></sec><sec sec-type="appendix" id="s8-6"><title>Global root mean square deviation (gRMSD)</title><p>The RMSD measures the average deviation of a protein’s atomic positions from a reference structure, typically the starting conformation. gRMSD provides an overview of the protein’s structural deviation over time. In our case, trajectories were first aligned, and Cα RMSD was calculated using MDAnalysis v2.7.0 (<xref ref-type="bibr" rid="bib34">Gowers et al., 2016</xref>; <xref ref-type="bibr" rid="bib56">Michaud-Agrawal et al., 2011</xref>), utilizing the starting conformation of each protein as a reference.</p></sec><sec sec-type="appendix" id="s8-7"><title>Partial root mean square deviation (pRMSD)</title><p>This CV is calculated similarly to gRMSD but focuses on specific residues or regions of interest. pRMSD provides insight into the structural stability of functionally important areas of the protein by focusing on catalytical residues and essential loops.</p></sec><sec sec-type="appendix" id="s8-8"><title>Dynamical root mean square deviation (dRMSD)</title><p>dRMSD is an extension of RMSD that considers the dynamic nature of protein motions by analysing fluctuations over time rather than static deviations. More specifically, instead of calculating RMSD to a fixed reference structure, it focuses on the difference between adjacent frames. This approach allows the analysis of short-timescale fluctuations and provides insight into the dynamic nature of protein motions over time. It was also calculated using MDAnalysis v2.7.0 (<xref ref-type="bibr" rid="bib34">Gowers et al., 2016</xref>; <xref ref-type="bibr" rid="bib56">Michaud-Agrawal et al., 2011</xref>) focusing on the Cα and offers a more nuanced understanding of the protein’s conformational landscape.</p></sec><sec sec-type="appendix" id="s8-9"><title>Global solvent-accessible surface area (gSASA)</title><p>SASA quantifies the surface area of the protein accessible to the solvent. gSASA was calculated using GROMACS v2020.1 (<xref ref-type="bibr" rid="bib1">Abraham et al., 2015</xref>) and provides information about the protein’s overall exposure to the solvent, which is relevant for understanding folding and binding interactions.</p></sec><sec sec-type="appendix" id="s8-10"><title>Partial solvent-accessible surface area (pSASA)</title><p>pSASA focuses on the solvent exposure of specific active site residues, offering insights into how binding sites or functional regions of the protein interact with the solvent.</p></sec><sec sec-type="appendix" id="s8-11"><title>Active site pocket volume</title><p>The volume of the active site pocket was calculated using Mdpocket (<xref ref-type="bibr" rid="bib83">Schmidtke et al., 2011</xref>). This CV is important for understanding the size and shape changes in the binding site, which can influence ligand binding and protein function. Upon importing the topology file and trajectories, Mdpocket autonomously identifies potential binding pockets within the protein structure. Subsequently, the relevant pocket was manually selected (<xref ref-type="fig" rid="fig2s3">Figure 2—figure supplement 3</xref>)</p></sec><sec sec-type="appendix" id="s8-12"><title>Number of hydrogen bonds (hbond)</title><p>The number of hydrogen bonds was calculated per frame using VMD v1.9.3 (<xref ref-type="bibr" rid="bib40">Humphrey et al., 1996</xref>), with a distance threshold of 3.5 Å and an angle cut-off of 40°. This CV provides insight into the stability of the protein structure and interactions that are critical for maintaining its conformation and function.</p></sec><sec sec-type="appendix" id="s8-13"><title>Residues and regions used in partial CVs</title><p>For SHV-1, the backbone torsion angles and χ1 angles for catalytic important residues—S70, T71, K73, S130, N132, K234, and T235—and Ω-loop residues (R164-D179) were used as the input feature to calculate the partial CVs. Similarly, for PDC-3, the backbone torsion angles and χ1 angles for catalytic important residues—K67, Y150, N152, K315, T316, and G317—Ω-loop residues (G183-S226), and R2-loop residues (L280-Q310) were utilized to calculate all the partial variables.</p></sec></sec></app><app id="appendix-2"><title>Appendix 2</title><sec sec-type="appendix" id="s9"><title>Other SHV-1 communities</title><p>Core residues for some of the communities identified by DyNoPy have never been studied in class A β-lactamases before. DyNoPy predicts these residues as essential due to their coevolution trends with many other residues and their critical role in class A β-lactamase dynamics (<xref ref-type="fig" rid="app2fig1">Appendix 2—figure 1</xref>).</p><p>D<sub>267</sub> is the core residue in community 3 (<xref ref-type="fig" rid="app2fig1">Appendix 2—figure 1A</xref>). This residue is located on the loop connecting β-sheet β9 and α-helix α12. It is outside the catalytic site and has not undergone essential substitutions, thus remaining unexplored in class A β-lactamases. However, DyNoPy indicates its potential importance due to its relationships with three known essential mutation sites: L<sub>35</sub>, E<sub>240</sub>, and A<sub>187</sub>. L<sub>35</sub> and E<sub>240</sub> are predominant ESBL mutation sites, while A<sub>187</sub> substitution confers an inhibitor-resistant phenotype (<xref ref-type="bibr" rid="bib20">Chang et al., 2001</xref>). The relationship between D<sub>267</sub> and these mutation sites suggests a trend towards coevolution, and interactions between D<sub>267</sub> and these mutation sites are important for protein dynamics.</p><p>Similarly, I<sub>279</sub>, located also on α12, is the core residue of community 8 (<xref ref-type="fig" rid="app2fig1">Appendix 2—figure 1B</xref>). This residue forms relationships with R<sub>244</sub>, a critical inhibitor resistant mutation site (<xref ref-type="bibr" rid="bib33">Giakkoupi et al., 1998</xref>). Other residues within this community are predominantly positioned on the α1 and α12 helices, near the protein’s terminus, highlighting the significant contribution of I<sub>279</sub> to protein integrity and stability.</p><p>For community 9, I<sub>155</sub> serves as the core residue (<xref ref-type="fig" rid="app2fig1">Appendix 2—figure 1C</xref>). This community is relatively localized and does not encompass any known essential residues. Most of the residues involved in this community are spatially close to each other, suggesting that I<sub>155</sub> plays a vital role in the local dynamics, especially surrounding α-helices α7 and α9.</p><fig id="app2fig1" position="float"><label>Appendix 2—figure 1.</label><caption><title>Communities 3, 8, and 9 of SHV-1 β-lactamase.</title><p>All the residues are depicted as spheres on the protein structure. The core residue for each community is D267, I279, and I155, respectively. They are highlighted in red. Functional important residues are marked in cyan. (<bold>A</bold>) Community 3 of SHV-1, comprising 31 residues. (<bold>B</bold>) Community 8 of SHV-1, containing 14 residues. (<bold>C</bold>) Community 9 of SHV-1, with 7 residues.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-105005-app2-fig1-v1.tif"/></fig></sec><sec sec-type="appendix" id="s10"><title>Other PDC-3 communities</title><p>The core residues in the other PDC-3 communities have not been extensively studied. However, their detection by DyNoPy suggests a significant trend in co-evolution and highlights their crucial role in protein dynamics (<xref ref-type="fig" rid="app2fig2">Appendix 2—figure 2</xref>). This emphasizes the capability of DyNoPy to predict essential residues in previously unexplored proteins, potentially offering valuable insights for future experimental research.</p><p>E<sub>49</sub>, D<sub>206,</sub> and R<sub>210</sub> are core residues for community 3, a small community containing only 14 residues (<xref ref-type="fig" rid="app2fig2">Appendix 2—figure 2A</xref>). R<sub>210</sub> is the primary core residue in this community, linking to six residues, while both E<sub>49</sub> and R<sub>210</sub> are secondary core residues that show a relationship with four residues. Unlike other communities with widespread interactions, community 3 illustrates a localized relationship among Ω-loop residues, primarily on the short β5a and β5b β-sheets and the short helix α7a. Also, 8 out of 14 residues are Ω-loop residues, with the remainder located on adjacent loops or near the terminals of adjoining secondary structures, all of which are flexible regions. This community indicates that R<sub>210</sub> is crucial for maintaining local structural integrity and the stability of the Ω-loop.</p><p>G<sub>202</sub>, the core residue of community 4, appears essential for active site stability by interacting with residues whose side chains point into the active site (<xref ref-type="fig" rid="app2fig2">Appendix 2—figure 2B</xref>). It also stabilizes two α-helices, α2 and α5, located adjacent to the active site. P<sub>154</sub> is a special mutation site in the PDC family. P<sub>154</sub>L occur in PDC-73 and PDC-81, giving the protein a mild increase in resistance to ceftazidime (<xref ref-type="bibr" rid="bib8">Berrazeg et al., 2015</xref>).</p><p>K<sub>204a</sub> and R<sub>207</sub> are the central residues in community 5, each establishing six interactions and thus sharing an equal position of importance within this community. K<sub>281</sub> and K<sub>351</sub>, which interact with both core residues, are highlighted in light yellow (<xref ref-type="fig" rid="app2fig2">Appendix 2—figure 2C</xref>). K<sub>204a</sub> forms direct interactions with six residues, primarily located on the opposite side of the active site, either on the R2 loop or at the beginning of helix α11. This suggests that K<sub>204a</sub> plays a crucial role in maintaining the conformation of the R2 site. Additionally, K<sub>204a</sub> shows direct correlations with the catalytically significant residue K<sub>315</sub>. Although R<sub>207</sub> is spatially close to K<sub>204a</sub>, it interacts with residues on loops that are distant from the catalytic site.</p><fig id="app2fig2" position="float"><label>Appendix 2—figure 2.</label><caption><title>Communities 3, 4, and 5 of PDC-3 β-lactamase.</title><p>All the residues are depicted as spheres on the protein structure. The core residue for each community is highlighted in red, while purple is used to emphasize the secondary core residue. Residues that interact with both cores are coloured in light yellow. Functional important residues are marked in cyan. (<bold>A</bold>) Community 3 of PDC-3, comprising 14 residues with R<sub>210</sub> being the primary core residue. (<bold>B</bold>) Community 4 of PDC-3, containing 25 residues and is centred by G<sub>202</sub>. (<bold>C</bold>) Community 5 of PDC-3, embracing 10 residues and having two core residues K<sub>204</sub> and R<sub>207</sub>.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-105005-app2-fig2-v1.tif"/></fig></sec></app></app-group></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.105005.3.sa0</article-id><title-group><article-title>eLife Assessment</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Gupta</surname><given-names>Yogesh K</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02f6dcw23</institution-id><institution>The University of Texas Health Science Center at San Antonio</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><kwd-group kwd-group-type="claim-importance"><kwd>Important</kwd></kwd-group><kwd-group kwd-group-type="evidence-strength"><kwd>Solid</kwd></kwd-group></front-stub><body><p>This article reports the analysis of coevolutionary patterns and dynamical information for identifying functionally relevant sites. These findings are considered <bold>important</bold> due to the broad utility of the unified framework and network analysis capable of revealing communities of key residues that go beyond the residue-pair concept. The data are <bold>solid</bold> and the results are clearly presented.</p></body></sub-article><sub-article article-type="referee-report" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.105005.3.sa1</article-id><title-group><article-title>Reviewer #1 (Public review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>Summary:</p><p>As reported above, this paper by Xu et al reports on a new method to combine the analysis of coevolutionary patterns with dynamic profiles to identify functionally important residues and reveal correlations between binding sites.</p><p>Strengths:</p><p>In general, coevolutionary analysis and MD analysis are carried out separately and while there have been attempts to compare the information provided by the two, no unified framework exists. Here, the authors convincingly demonstrate that integrating signals from Dynamics and coevolution gives information that substantially overcomes the one provided by either method in isolation. While other methods are useful, they do not capture how dynamics is fundamental to define function and thus sculpts coevolution, via the 3D structure of the protein. At the same time, the authors demonstrate how coevolution in turn also influences internal dynamics. The Networks they rebuild unveil information at an even higher level: the model starts pairwise but through network representation the authors arrive to community analysis, reporting on interaction patterns that are larger than simple couples.</p><p>Comments on latest version:</p><p>I have nothing to add to this revision. The paper looks excellent and very interesting.</p></body></sub-article><sub-article article-type="referee-report" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.105005.3.sa2</article-id><title-group><article-title>Reviewer #2 (Public review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>Summary:</p><p>The authors introduced a computational framework, DyNoPy, that integrates residue coevolution analysis with molecular dynamics (MD) simulations to identify functionally important residues in proteins. DyNoPy identifies key residues and residue-residue coupling to generate an interaction graph and attempts to validate using two clinically relevant β-lactamases (SHV-1 and PDC-3).</p><p>Strengths:</p><p>DyNoPy could not only show clinically relevance of mutations but also predict new potential evolutionary mutations. Authors have provided biologically relevant insights into protein dynamics which can have potential applications in drug discovery and understanding molecular evolution.</p><p>Comments on latest version:</p><p>I appreciate the efforts of the authors to address my comments.</p></body></sub-article><sub-article article-type="referee-report" id="sa3"><front-stub><article-id pub-id-type="doi">10.7554/eLife.105005.3.sa3</article-id><title-group><article-title>Reviewer #3 (Public review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>Summary:</p><p>In this paper, Xu, Dantu and coworkers report a protocol for analyzing coevolutionary and dynamical information to identify a subset of communities that capture functionally relevant sites in beta-lactamases.</p><p>Strengths:</p><p>The combination of coevolutionary information and metrics from MD simulations is interesting for capturing functionally relevant sites, which can have implications in the fields of drug discovery but also in protein design.</p><p>Comments on latest version:</p><p>The authors have successfully addressed all my previous comments/concerns. I am happy with the current version of the manuscript.</p></body></sub-article><sub-article article-type="author-comment" id="sa4"><front-stub><article-id pub-id-type="doi">10.7554/eLife.105005.3.sa4</article-id><title-group><article-title>Author response</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Xu</surname><given-names>Manming</given-names></name><role specific-use="author">Author</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02jx3x895</institution-id><institution>University College London</institution></institution-wrap><addr-line><named-content content-type="city">London</named-content></addr-line><country>United Kingdom</country></aff></contrib><contrib contrib-type="author"><name><surname>Dantu</surname><given-names>Sarath Chandra</given-names></name><role specific-use="author">Author</role><aff><institution>Brunel University London</institution><addr-line><named-content content-type="city">Uxbridge</named-content></addr-line><country>United Kingdom</country></aff></contrib><contrib contrib-type="author"><name><surname>Garnett</surname><given-names>James A</given-names></name><role specific-use="author">Author</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0220mzb33</institution-id><institution>King's College London</institution></institution-wrap><addr-line><named-content content-type="city">London</named-content></addr-line><country>United Kingdom</country></aff></contrib><contrib contrib-type="author"><name><surname>Bonomo</surname><given-names>Robert A</given-names></name><role specific-use="author">Author</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/051fd9666</institution-id><institution>Case Western Reserve University</institution></institution-wrap><addr-line><named-content content-type="city">Cleveland</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Pandini</surname><given-names>Alessandro</given-names></name><role specific-use="author">Author</role><aff><institution>Brunel University London</institution><addr-line><named-content content-type="city">Uxbridge</named-content></addr-line><country>United Kingdom</country></aff></contrib><contrib contrib-type="author"><name><surname>Haider</surname><given-names>Shozeb</given-names></name><role specific-use="author">Author</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02jx3x895</institution-id><institution>University College London</institution></institution-wrap><addr-line><named-content content-type="city">London</named-content></addr-line><country>United Kingdom</country></aff></contrib></contrib-group></front-stub><body><p>The following is the authors’ response to the original reviews.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #1 (Public review):</bold></p><p>Summary:</p><p>As reported above, this paper by Xu et al reports on a new method to combine the analysis of coevolutionary patterns with dynamic profiles to identify functionally important residues and reveal correlations between binding sites.</p><p>Strengths:</p><p>In general, coevolutionary analysis and MD analysis are carried out separately and while there have been attempts to compare the information provided by the two, no unified framework exists. Here, the authors convincingly demonstrate that integrating signals from Dynamics and coevolution gives information that substantially overcomes the one provided by either method in isolation. While other methods are useful, they do not capture how dynamics is fundamental to define function and thus sculpts coevolution, via the 3D structure of the protein. At the same time, the authors demonstrate how coevolution in turn also influences internal dynamics. The Networks they rebuild unveil information at an even higher level: the model starts pairwise but through network representation the authors arrive to community analysis, reporting on interaction patterns that are larger than simple couples.</p><p>Weaknesses:</p><p>The authors should</p><p>- Make an effort in suggesting/commenting the limits of applicability of their method;</p></disp-quote><p>We have added a sentence on Page 17, line 15 that describes the limitation of our method.</p><disp-quote content-type="editor-comment"><p>- Expand discussion on how DyNoPy compares to other methods;</p></disp-quote><p>A paragraph has been added to explain the comparison with other models (Page 3, line 18)</p><disp-quote content-type="editor-comment"><p>- Dynamic is not essential in all systems (structural proteins): The authors may want to comment on possible strategies they would use for other systems where their framework may not be suitable/applicable.</p></disp-quote><p>We agree with the reviewer that dynamics is not essential in all systems. In systems where there is limited role of dynamics in the function, the analysis done with DyNoPy is equivalent to conventional coevolution analysis, which can be consider one limitation of our method. Conversely, for dynamic proteins, combining functional dynamics descriptors with coevolution analysis using DyNoPy, helps in denoising information by deconvolution of communities. We have included this in the manuscript to highlight the suitability/applicability of the method.</p><p>Further, we have added a paragraph in the Introduction and conclusions highlighting the main difference between DyNoPy and existing computational tools like DCCM, KIN, and SPM and for your convenience it is provided below:</p><p>“Functional sites are often regulated by both, local and global interactions. Changes in these interactions are instrumental for functional events like substrate binding, catalysis, and conformational changes (18). The development of physical models of protein dynamics and the increase in available computational power has stimulated the adoption of computational techniques (19, 20) to investigate the conformational dynamics of proteins, an essential component of the many biological functions (21, 22). Different models have been proposed to describe the interactions between residues during simulations and network models have been particularly popular, including methods on single structures and MD simulations data built by analysing the response to external forces on residue networks (23), by estimating the prevalence of non-covalent energy interaction networks in homologous proteins (24), or by analysing linear or non-linear correlation in atomic fluctuations (25, 26). These techniques have demonstrated their usefulness in extracting allosteric networks from structural data with applications in enzyme design (26).”</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #2 (Public review):</bold></p><p>Summary:</p><p>Authors introduced a computational framework, DyNoPy, that integrates residue coevolution analysis with molecular dynamics (MD) simulations to identify functionally important residues in proteins. DyNoPy identifies key residues and residue-residue coupling to generate an interaction graph and attempts to validate using two clinically relevant β-lactamases (SHV-1 and PDC-3).</p><p>Strengths:</p><p>DyNoPy could not only show clinically relevance of mutations but also predict new potential evolutionary mutations. Authors have provided biologically relevant insights into protein dynamics which can have potential applications in drug discovery and understanding molecular evolution.</p><p>Weaknesses:</p><p>Although DyNoPy could show the relevance of key residues in active and non-active site residues, no experiments have been performed to validate their predictions.</p></disp-quote><p>We thank the reviewer for highlighting this point. We acknowledge that direct experimental validation of our predictions for DyNoPy has not yet been performed. However, we have provided explanations and evidence from experiments conducted on closely related homologs to support the relevance of key residues. These homologs share significant structural and functional similarity, which strengthens the reliability of our predictions.</p><disp-quote content-type="editor-comment"><p>In addition, they should compare their method with conventional techniques and show how their method could be different.</p></disp-quote><p>We thank all the reviewers for highlighting this oversight on our behalf. In Introduction and conclusion, we have added the following paragraphs:</p><p>“Functional sites are often regulated by both, local and global interactions. Changes in these interactions are instrumental for functional events like substrate binding, catalysis, and conformational changes (18). The development of physical models of protein dynamics and the increase in available computational power has stimulated the adoption of computational techniques (19, 20) to investigate the conformational dynamics of proteins, an essential component of the many biological functions (21, 22). Different models have been proposed to describe the interactions between residues during simulations and network models have been particularly popular, including methods on single structures and MD simulations data built by analysing the response to external forces on residue networks (23), by estimating the prevalence of non-covalent energy interaction networks in homologous proteins (24), or by analysing linear or non-linear correlation in atomic fluctuations (25, 26). These techniques have demonstrated their usefulness in extracting allosteric networks from structural data with applications in enzyme design (26). ”</p><disp-quote content-type="editor-comment"><p>An explanation of &quot;communities&quot; divided in the work and how these communities are relevant to the article should be provided. In addition, choice of collective variables and their relevance in residue coupling movement is also not very well explained. Dynamics cross correlation map can also be a good method for understanding the residue movements and can explain the residue-residue coupling, it is not explained how DyNoPy is different from the conventional methods or can perform better.</p></disp-quote><p>The following sentences have been included in the manuscript to address the questions raised by the reviewer:</p><p>On Community Definition and relevance</p><p>DyNoPy identified coevolving residue pairs (scaled coevolution score &gt;1) with interactions strongly correlated with protein functional motions (i.e., J values larger than zero). Applying network analysis on the combined dynamics-coevolution matrix helps us extracting higher-order interactions beyond pairwise coupling and detecting critical residues, which show multiple interactions with each other. Moreover, indirect long-range relationships, which would be hard to identify from numerical data, could be detected through community clustering. Community-based analysis offers a more comprehensive understanding of residue relationships and enables the visualization of residue couplings on the protein structure.</p><p>On Choice of collective variables:</p><p>DyNoPy works on the assumption that time-dependent interactions between critical residues, either having significant structural change or not will correlate with functional conformational motions. Since MD simulation data is high-dimensional, a time-dependent dynamic descriptor is required to extract the most relevant information for the process under study. A good collective variable (CV) should appropriately describe protein functional motions. Thus, a CV that detects the highest number of residue couplings is expected to be the most suitable descriptor (Mentioned in Page 22 Line 14). In our study, we tested 12 CVs, either focusing on the entire protein or on selected regions. And the best performed CV (the one identified the most residue couplings) was selected for further analysis. In practical applications, users can decide whether to focus on the most relevant global or local dynamics descriptor depending on the dynamics of their specific system.</p><p>We have added a paragraph in the Introduction differentiating DyNoPy with other methods including DCCM. DCCM differs from DyNoPy in two aspects (1) it does not account for inter-residue coevolution (2) the correlation matrix captures correlations of atomic/residue movements associated with the whole intrinsic dynamics of the system, without filtering for the contributions to the important motions involved in the biological function. Additionally, any residue pair contributing to functional motion without itself undergoing any structural change will not be visible in this approach.</p><disp-quote content-type="editor-comment"><p>In the sentence &quot;DyNoPy identified eight significant communities of strongly coupled residues within SHV-1 (Supporting Fig. S4A)&quot; I could not find a clear description of eight significant communities.</p></disp-quote><p>The following sentences have been included in the results, methods and figure legends that define ‘significant community’:</p><p>‘DyNoPy identified eight meaningful communities, each consisting of at least three strongly coupled residues within SHV-1 (Supplementary Fig. S4A). All crucial catalytic residues and critical substitution sites previously mentioned participating in one of these communities with the exceptions of R<sub>43</sub>, R<sub>202</sub>, and S<sub>130</sub>.’ (Page 8 Line 28)</p><p>‘A meaningful community should contain at least three residues.’ (Page 21 Line 2)</p><p>‘A reasonable residue community should contain at least three residues.’ (SI Page 11)</p><disp-quote content-type="editor-comment"><p>Again the description of communities is not clear to me in the following sentence &quot;Detailed description of the other three communities is provided in the supporting information (Fig. S6).&quot;</p></disp-quote><p>This following sentence has been rewritten.</p><p>‘Detailed description of communities with secondary importance for protein function (community 3, 8, and 9) is provided in the supplementary information (Supplementary Fig. S6).’ (Page 9, line 8)</p><disp-quote content-type="editor-comment"><p>In the sentence &quot;N170 acts as an intermediary between N136 and E166&quot;. Kindly cite the reference figure to show N179 as intermediate residue.</p></disp-quote><p>This sentence has been rewritten to avoid any confusion.</p><p>‘Although DyNoPy did not detect this direct interaction between N136 and E166, the established relationship between N136 and N170 highlights the role of N136 in influencing E166.’ (Page 10 Line 8)</p><disp-quote content-type="editor-comment"><p>Please be careful with the numbers. In the sentence &quot;These residues not only interact with each other directly but are also indirectly coupled via 21 other residues.&quot; I could count 22 other residues and not 21.</p></disp-quote><p>We thank the reviewer for spotting this error. This has now been corrected. All the communities are counted again.</p><p>‘These residues not only interact with each other directly but are also indirectly coupled via 22 other residues.’ (Page 12 Line 14)</p><disp-quote content-type="editor-comment"><p>In the sentence &quot;Unlike other substitution sites that are adjacent to the active site, R<sub>205</sub> is situated more than 16 Å away from catalytic serine S<sub>70</sub>&quot;. Please add this label somewhere in the figure.</p></disp-quote><p>The figure legends have been updated to include this. Distances have been added to community 4 Fig. 3 and community 6 Fig. 4. Residue index in the legend of Fig.3 has been included as subscript. Distance in the main text has been changed to be more accurate.</p><p>‘G<sub>156</sub> and A<sub>146</sub> are two functional important residues distant from the active site. G<sub>156</sub> is 21.3Å away from the catalytic S<sub>70</sub>. A<sub>146</sub> is 16.8Å away from S<sub>70</sub>.’ (Page 12 Line 2)</p><p>‘R<sub>205</sub> is a functional important residue that is 20.6Å away from the active site S<sub>70</sub>.’ (Page 13 Line 10)</p><disp-quote content-type="editor-comment"><p>Please cite a reference in the sentence &quot;This indicates that mutations on G238 would result in an alteration on protein catalytic function, as well as an increased flexibility of the protein, which strongly aligns with previous finding.&quot;</p></disp-quote><p>The citation has been added</p><p>‘This indicates that mutations on G238 would result in an alteration on protein catalytic function, as well as an increased flexibility of the protein, which strongly aligns with previous finding (62).’ (Page 15 Line 2)</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #3 (Public review):</bold></p><p>Summary:</p><p>In this paper, Xu, Dantu and coworkers report a protocol for analyzing coevolutionary and dynamical information to identify a subset of communities that capture functionally relevant sites in beta-lactamases.</p><p>Strengths:</p><p>The combination of coevolutionary information and metrics from MD simulations is interesting for capturing functionally relevant sites, which can have implications in the fields of drug discovery but also in protein design.</p><p>Weaknesses:</p><p>The combination of coevolutionary information and metrics from MD simulations is not new as other protocols have been proposed along the years (the current version of the paper neglects some of them, see below), and there are a few parameters of the protocol that, in my opinion, should be better analyzed and discussed.</p><p>(1) As mentioned, the introduction of the paper lacks some important publications in the field of using graph theory to represent important interaction networks extracted from MD simulations (DOI: 10.1002/pro.4911), and also combining MD data with MSA to identify functionally relevant sites for enzyme design (doi: 10.1021/acscatal.4c04587, 10.1093/protein/gzae005).</p></disp-quote><p>We are very grateful for pointing us to these references. We have added a paragraph in the Introduction mentioning these and other computational tools similar to DyNoPy. Further, in conclusion we have highlighted the differences between DyNoPy and existing tools.</p><disp-quote content-type="editor-comment"><p>(2) The matrix used to apply graph theory (J_ij) is built from summing the scaled coevolution and degree of correlation values. The alpha and beta weights are defined, and the authors mention that alpha is set to 0.5, thus beta as well to fulfil with the alpha + beta = 1. Why a value of 0.5 has been selected? How this affects the overall results and conclusions extracted? The finding that many catalytically relevant residues are identified in the communities is not surprising given that such sites usually present a high conservation score.</p></disp-quote><p>This is an excellent question. Our present formulation allows the user to easily assess the influence of coevolution and dynamic couplings on the output. Setting alpha to 0.5, weights both evolutionary and dynamics information equally and has shown promising results in SHV-1 and PDC-3. As it has been presented in the manuscript, setting alpha to 1, i.e., purely utilising coevolution data does not let us identify critical residues effectively as all residues are included in the set (Supplementary Fig. S4 and S5). In future work, we would like to investigate the effect of scanning alpha from 0 to 1 on the final residue list, possibly on a larger set of proteins and protein families.</p><p>We would also like to point out that some of the residue pairs with coevolution scores in the top 1% have J-scores set to 0, as they lacked significant coupling to the functional dynamics.</p><disp-quote content-type="editor-comment"><p>(3) Another important point that needs further explanation is the selection of the relevant descriptor of protein dynamics. In this study two different strategies have been used (one more global the other more local), but more details should be provided regarding their choice. What is the best strategy according to the authors? Why not using the same strategy for both related systems? The obtained results using one methodology or the other will have a large impact on the dynamical score. Another related point is: what is the impact of the MD simulation length, how the MSA is generated and number of sequences used for MSA construction?</p></disp-quote><p>As in the case of many complex proteins, the flow of information occurs in β-lactamases via structural interactions (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.7554/eLife.66567">https://doi.org/10.7554/eLife.66567</ext-link>). These interactions occur both on a local level, as in the case of binding site residues or residues immediately surrounding the binding site; however, there are interactions far away (&gt;20Å) from the binding site that have the ability to alter function. We have obtained this information from extensive surveys of clinical isolates and experimental data. To account for such interactions, a more global approach has to be taken. To answer the reviewer’s question: each system is unique and there is no one-fixed strategy. In short, the method used should be able to denoise information and the user is advised to fine-tune their findings by corroborating with experimental and clinical information.</p><p>The length of MD simulations is also system specific. Some systems effectively sample the functional dynamics within a shorter simulation time, while others take a long timescale MD simulation to converge. The results won’t change as long as the simulation has effectively sampled the functional dynamics associated with biological function.</p><p>The MSA is generated by the HH-Suite package as mentioned on Page 19 Line 19. More specifically, the MSA is constructed based on the UniRef30 database, where sequences are clustered, and each cluster contains sequences with at least 30% sequence identity. This provides a non-redundant set of protein sequences. Our package allows the automatic generation of MSAs from the database. For SHV-1, the alignment contains 18,175 protein sequences and for PDC-3, the alignment consists of 27,892 protein sequences. Full details of this protocol are published in Bibik et al. (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/bioinformatics/btae166">https://doi.org/10.1093/bioinformatics/btae166</ext-link>). We have revised the methods section to include these details.</p><p>Other Minor Alterations</p><p>‘Fig. S1 and S2’ has been changed to ‘Supplementary Fig. S1 and S2’ for consistency (Page 6 Line 12)</p><p>(1) ‘Figure 5B’ has been changed to ‘Fig. 5B’ for consistency (Page 16 Line 11)</p><p>(2) All the ‘Figure’ has been changed to ‘Fig.’ in the SI for consistency</p><p>(3) Just as the suggestion, an alteration has been made on the Step 1 of Fig.1.</p></body></sub-article></article>